Infosys Ltd (INFY) — Council Assessment

🟡 WATCH · Score 54/100 · medium confidence

High-quality, debt-free IT services franchise with a fortress balance sheet but a stalled organic growth engine (~0.8%) and genuine AI-deflation risk — fairly priced, not cheap, and not a clear buy.

As of 2026-08-17. 19 lenses weighed in, 0 abstained. Sources: 4 filings, 26 news, 25 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

INFOSYS LTD. (INFY) — Investment Briefing

---

Management Commentary (Earnings Call)

Infosys reported Q1 FY27 results on 24 July 2026, with net profit climbing 12% to ₹7,769 Cr. Key takeaways:

Guidance & Growth

• Revenue guidance cut sharply from prior ~2.5% midpoint to 1.5–3% YoY (constant currency). Organic growth ~0.8% ex-acquisitions, implying a ~170 bps downward revision.
• Operating margin maintained at 20–22%, but with caveats (wage hikes, acquisition drag, offset by currency tailwinds & Project Maximus).

AI Momentum (Bright Spot)

• AI revenues at 8.2% of total, up from 5.5% in Q3 FY26, growing double-digit sequentially for several quarters.
• Six-area AI strategy (process automation, AI engineering, data for AI, coding tools, modernization, etc.) showing "strong traction."
• Building 6,000 "frontier engineers" and developed Topaz Fabric platform (multi-model, data-sovereign, token-cost optimized).
• Pipeline "healthy"; management sees AI as long-term growth engine (analogy: digital went from 20% → 60% of revenue over years).

Headwinds & Margin Pressure

1. One-time client termination (~50 bps impact, Q1 only) in an EORS vertical client.
2. Soft volumes and weaker-than-expected pricing (clients demanding AI-led productivity deflation; competitive intensity rising).
3. Project margin mix: Large deals have declined ACVs due to renewals carrying incremental productivity reductions ("AI deflation").
4. Offshoring shift (75–100 bps expected on-site reduction), lower European manufacturing client spend, macro uncertainty.
5. Wage hikes (effective Oct 2026 & Jan 2027; only half-year impact vs FY26's full-year impact).
6. Acquisition headwinds (Optum Health, Tastus): 50 bps margin drag from intangibles amortization, retention costs.

Margin Management

Q1 operating margin improved 20 bps sequentially to 21.1%, driven by:

• +70 bps: rupee depreciation
• +20 bps: Project Maximus operational efficiency
• –50 bps: AI sales/marketing investment
• –40 bps: one-time client termination
  Utilization (ex-trainees) up 190 bps to 84.9%.

Leadership Transition

• Salil Parekh's term ends 31 Mar 2027. Ashish Dash (31-year Infosys veteran, ex-IIT Kharagpur, background in delivery, sales, account mgmt) announced as CEO designate starting Mar 2027.
• Parekh to mentor Dash for ~6 months in transition role.
• Market/analyst reception noted as positive internally and with customers.

Large Deals & Backlog

• $3.6B in large-deal wins, 61% net new.
• 51% of CCV from new vendor consolidation deals (client tech rationalization), though pricing compressed on those.
• Deal terms: mostly 3–5 years; some mega-deals up to 5 years; most recent deals <$500M.

Analyst Q&A Themes

• Pricing pressure: Morgan Stanley, Duvenheim asked why April guidance had not baked in competitive headwinds. Management acknowledged softness through Q1, blamed cascading volume impact and late-quarter termination/deal losses.
• TCV vs. ACV dynamics: Large-deal TCV lengths stable (3–5 yr avg), but ACVs compressed due to incremental productivity deflation at renewals, offset partially by adjacent work scope.
• Talent competition: Amazon/Microsoft/Google entering services space seen as validation of market, not threat. Infosys leveraging 300k headcount, deep client context, partnerships with hyperscalers.
• AI revenue definition: "AI-first" = six hexagon pools (8.2% of revenue). "AI-augmented" tracked internally but not externally reported.

---

Recent Developments

1. Guidance Revision (24 Jul 2026): Cut FY27 growth to 1.5–3% YoY vs. prior ~2% midpoint. Includes ~1.7% from recent acquisitions (Optum Health, Tastus), implying ~0.8% organic growth.
2. CEO Succession Announced: Ashish Dash to take over from Salil Parekh on 31 Mar 2027, with 6-month mentorship overlap.
3. Q1 Results: Net profit +12% YoY (₹7,769 Cr), revenue +2.4% YoY / +1% QoQ (const curr). EPS up 15% in rupee terms.
4. Large-Deal Wins: 22 large deals signed; 20% of CCV from vendor consolidation; strong in FS/Banking (5 deals), Comms (5), URLs (4), Manufacturing (3).
5. Headcount: Reduced 500 in Q1 (net); planning 20k college grad hires for FY27 (4k+ in Q1 already). Attrition stable at 13%.

---

Bull Narrative

Proponents' Key Arguments:

1. AI Growth Engine: 8.2% AI revenue growing double-digit sequentially, doubling from 5.5% in two quarters. Topaz Fabric and frontier engineer program position Infosys ahead of peers in client AI deployment. Analogy to digital transition suggests massive runway.
2. Vendor Consolidation Opportunity: 20% of large-deal CCV from vendor rationalization; clients seeking to simplify tech stacks. Infosys's deep client relationships and proven delivery give competitive edge.
3. Margin Resilience: Despite wage hikes and acquisition drag, management confident in 20–22% guidance. Project Maximus delivering, currency tailwinds present, utilization improving.
4. Healthy Pipeline & Deal Momentum: $3.6B in large-deal wins (61% net new) shows client demand for transformation. FS/Banking clients increasingly investing in AI strategy/platforms.
5. Strong Cash Generation: Free cash flow +16.5% of net profit; dividends >$1B returned in quarter; balance sheet debt-free with $3.9B cash.
6. Valuation Reprieve: Post-earnings stock surge ~16% in 5 days suggests oversold sentiment clearing. Options flow (100k+ Aug $15 calls) hints at institutional optimism.

Retail Sentiment: Bullish, conviction moderate–high. Recurring themes: "Leads IT outsourcing," "INFY $16 soon," "up 10% since we told you," "looks good 💪." Some attribution to AI tailwinds and CEO transition as positive.

---

Bear Narrative

Skeptics' Key Arguments:

1. Growth Collapse: FY27 guidance of 1.5–3% is barely above zero in real terms. Organic growth (ex-acquisitions) ~0.8%—a near-stall. Volumes "softer than expected," pricing below plan; management admits macro remains uncertain.
2. AI Deflation Risk: While AI revenue is 8.2%, the rest of the portfolio faces "AI-led deflation" (client productivity demands at renewals). Management acknowledges this but won't quantify compression. Risk that AI growth cannibalizes legacy margins.
3. Multiple Client-Specific Headwinds: European manufacturing client (ongoing), EORS program termination (Q1), conscious deal rejections due to poor ROI. These are not one-off; suggest structural demand softness and disciplined pricing (margin sacrifice).
4. Wage & Acquisition Drag: Wage hikes in H2 FY27, intangibles amortization from recent M&A, retention costs. Full-year margin pressure despite 20–22% guidance assumption.
5. Leadership Vacuum: Salil Parekh, who grew company from $10B to $20B, departs Mar 2027. Ashish Dash, though 31-year insider, is unproven as CEO in a transformational era. Transition risk real.
6. Competitive Intensity Rising: Pricing headwinds explicitly called out; hyperscalers (AWS, Azure, Google) launching own services arms. Analyst downgrades (JPMorgan to Neutral, $10.90 tgt; HSBC to Hold) suggest Street losing confidence.
7. Stock Valuation Risk: Surge post-earnings may be short-covering or squeeze. GuruFocus notes "still undervalued," but bear thesis implies P/E multiple likely to compress if growth stalls <2%.

Retail Sentiment (Bearish Minority): "8-11 trade range until Dec," "AI replacing IT companies" (HCL losing work to AI), data leak at Bank of Baroda (Infosys Finacle client reputational risk).

---

Caveats & Coverage Gaps

1. AI Revenue Opacity: 8.2% figure is "AI-first" (hexagon strategy only); "AI-augmented" internally tracked but not disclosed. Actual AI contribution likely higher, but exact mix/margin profile of AI work unclear. Risk of double-counting or inflated narrative.

2. Pricing Compression Unquantified: Management acknowledges AI deflation but refuses to disclose magnitude. Large-deal ACVs declining at renewals, but "adjacent work" sometimes offsets—no external visibility on net P&L impact.

3. Macro Assumptions Vague: "Improvement in macro" baked into guidance, but management admits uncertainty. No industry-specific color on which verticals (FS, Mfg, Comms, Retail) are stabilizing vs. deteriorating.

4. Transition Risk Under-explored: CEO succession timeline (6-month mentorship) unusual for a $20B enterprise. Ashish Dash's lack of public profile / C-suite track record a material unknown.

5. Acquisition Integration: Optum Health and Tastus contributions still opaque. Earn-out terms, client overlap, integration timeline not detailed.

6. Analyst Downgrades Post-Call: JPMorgan (Neutral, $10.90) and HSBC (Hold) downgrades on 24 Jul suggest Street skepticism not fully priced. Stock rally into call may have been front-run.

7. Retail Hype vs. Fundamentals: Retail bullish sentiment ("$16 soon," large options buying) may be momentum-driven, not based on revised fundamentals. 100k+ call contracts unusual; suggests speculative flow rather than conviction.

---

Summary

Infosys faces a critical inflection: AI opportunity is real and growing at impressive speed, but organic revenue growth has stalled, pricing is under pressure, and the company is navigating leadership transition. Management's posture—maintaining margin guidance while cutting revenue growth—suggests confidence in cost discipline but limited confidence in demand recovery. The 8.2% AI revenue, if it scales to 15–20% over next 3 years as analogy to digital suggests, could be transformational; but near-term (FY27–28) is a low-single-digit growth slog with margin volatility.

Key watch: Q2 results (Oct 2026) and Dash's first quarter as CEO (FY28 Q1, late 2027) will reset expectations. Until then, stock likely trades on AI narrative vs. growth reality—a volatile frame for cautious investors.

Bull case

Infosys is a capital-light, debt-free franchise (~$3.9B cash per narrative) with stable ~20-21% operating margins (20.3% FY26 per 20-F), disciplined capital return (~85% FCF policy, ₹18,000 crore buyback approved Sep 2025, ₹25/share dividend), and genuine switching-cost moats in deeply embedded enterprise systems. AI revenue at 8.2% of total is growing double-digit sequentially and — if it follows the digital-to-60% analogy — could become a real growth engine. $3.6B large-deal wins (61% net new) show the franchise still wins mandates. The forensic short-seller found no accounting red flags. Valuation (~2.4x sales, ~9% EBIT/EV per Greenblatt, ~1.4x EPV per Greenwald) is fair, not stretched.

Bear case

Organic growth has effectively stalled at ~0.8% ex-acquisitions; FY27 guidance was cut mid-year to 1.5-3%, denting management forecasting credibility. The same AI touted as a growth engine is compressing pricing on the other ~92% of the book via acknowledged 'AI-led deflation' at renewals — a moat-erosion signal that management refuses to quantify. The Christensen referee (48, high confidence) frames the core labor-arbitrage model as the textbook target for low-end AI disruption, with hyperscalers building competing services arms. Greenwald pegs market cap ~40% above EPV. Druckenmiller and Schloss both say Avoid: decelerating second derivative, no tangible-asset floor, and a post-earnings rally that has already absorbed the fear discount. Margin trended down (21.1%→20.3% YoY) with wage hikes and acquisition amortization drag ahead.

Dissent — where the council disagrees

Two lenses break Avoid: Druckenmiller (28) — the earnings/revenue second derivative is negative, no near-term catalyst, negative estimate revisions (JPMorgan Neutral $10.90, HSBC Hold), and the post-earnings pop looks like short-covering, not leadership; and Schloss (22) — an intangible-heavy business with no hard-asset floor rallying off its lows is the antithesis of a bargain. The AI/Disruption referee (48, the only HIGH-confidence lens) is the most important dissent for a long-term owner: it argues the core human-expertise revenue base is exactly what LLMs commoditize from the bottom up, and take-rate compression is ALREADY visible in ACV deflation. Against them, the forensic short-seller's PASS (72) is narrow — explicitly 'absence of red flags, not endorsement of the outlook.' The tension: bulls own the balance sheet and AI optionality; skeptics own the growth trajectory and the disruption thesis. That gap keeps this off a clean Pass.

Key risks

• AI-led pricing deflation compressing ACVs on the ~92% legacy book faster than the 8.2% AI revenue can offset — magnitude unquantified by management (moat-erosion, structural not cyclical)
• Organic growth near stall (~0.8%); if global IT budgets contract, revenue could turn negative given discretionary-spend exposure
• Hyperscaler (AWS/Azure/Google) services-arm competition disintermediating both tooling and advisory layers
• CEO succession (Parekh → unproven Dash, Mar 2027) at a critical AI inflection with only a 6-month overlap
• Data gap: DCF flagged not-applicable on missing/negative FCF (likely artifact given narrative's positive FCF), and null ROE/current ratio/D-E prevent rigorous return-on-capital verification — reduces confidence
• Acquisition (Optum Health, Tastus) integration opacity and 50 bps margin drag; ROIC of deals unverifiable
• Margin compression trajectory (21.1%→20.3%) with wage hikes (Oct 2026, Jan 2027) and amortization drag ahead

Catalysts

• Q2 FY27 (October) results confirming whether organic growth stabilizes or deteriorates further
• AI revenue scaling toward 15%+ of total with an improving margin profile (bull disconfirmation of disruption thesis)
• Guidance revision — upward (reaccel) or further cut (validating bear)
• CEO transition execution and client retention through the Dash handover
• Continued buyback execution / dividend increases supporting per-share value
• Vendor-consolidation deal wins converting to revenue vs. TCV/ACV gap widening

DCF valuation

Not applicable: negative or missing free cash flow — DCF not meaningful.

Short-sell evaluation

🚫 AVOID SHORTING

Despite decelerating fundamentals and a plausible AI-disruption thesis, Infosys is a poor short. The forensic short-seller found no accounting, governance, or financing red flags; the balance sheet is debt-free with ~$3.9B cash, capital return is aggressive (85% FCF, buybacks + >$1B dividends), and margins remain in the healthy 20-21% band. The stock already fell hard and rallied ~16% on the print, so the easy fear-driven downside is likely spent, and crowded bullish retail/options flow adds squeeze risk. Valuation is fair (~2.4x sales, ~9% EBIT/EV), not the bubble a short needs. A short here bets that AI deflation overwhelms AI growth on a multi-quarter view — a real risk, but slow-burning, well-telegraphed, and offset by cash generation and buybacks. This is a specialist thematic short at best, not an attractive setup.

Pros (the short could work)

• Decelerating growth: FY27 organic ~0.8%, guidance cut mid-year — negative second derivative (Druckenmiller)
• Overvaluation vs. intrinsic: Greenwald pegs market cap ~40% above EPV; valuation referee says price implies 5-7% growth vs. 0.8% reality
• Structural AI-deflation eroding pricing power on the legacy book (Christensen referee, high confidence)
• Hyperscaler disintermediation threat to the core services moat
• Negative analyst revision momentum (JPMorgan Neutral $10.90, HSBC Hold); margin compression trend

Cons (what kills the short)

• No forensic/accounting red flags — the short-seller lens itself scored PASS (72); no earnings-cash divergence, restatements, or governance rot found
• Fortress balance sheet: debt-free, ~$3.9B cash, strong FCF — nothing forces a collapse
• Aggressive buybacks (₹18,000 cr) and >$1B dividends provide a bid and shrink share count against the short
• Crowded bullish retail sentiment / heavy call open interest → squeeze risk after a 16% pop
• Valuation is only fair, not bubbly — limited downside vs. the unlimited-loss asymmetry of a short
• Fear-driven downside likely already realized; borrow cost/carry on a dividend payer works against you

Council scorecard

Lens	School	Stance	Score	Conf
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟢 pass	72	medium
Warren Buffett	quality	🟡 watch	58	medium
Valuation Referee (Damodaran-style)	referee	🟡 watch	58	medium
Charlie Munger	quality	🟡 watch	58	medium
Chuck Akre	quality	🟡 watch	55	medium
Joel Greenblatt	value	🟡 watch	55	medium
Michael Mauboussin	quality	🟡 watch	55	medium
Terry Smith (Fundsmith)	quality	🟡 watch	55	medium
Ray Dalio	risk	🟡 watch	52	medium
Philip Fisher	growth	🟡 watch	52	medium
Benjamin Graham	value	🟡 watch	52	medium
Bruce Greenwald	value	🟡 watch	52	medium
Peter Lynch	growth	🟡 watch	52	medium
Howard Marks	risk	🟡 watch	52	medium
AI & Disruption Referee (Christensen-style)	referee	🟡 watch	48	high
Seth Klarman	value	🟡 watch	45	medium
Paul Singer	value	🟡 watch	42	medium
Stanley Druckenmiller	risk	🔴 avoid	28	medium
Walter Schloss	value	🔴 avoid	22	medium

Member reasoning

Forensic Short-Seller (Chanos/Einhorn-style) — 🟢 pass · 72/100 · medium confidence

Forensic short-selling requires finding earnings-cash divergence, aggressive accounting, governance rot, or structural financing dependence. On none of these dimensions does Infosys present a compelling short thesis from the available fact base. The 20-F (filed 2026-06-15, period ending 2026-03-31) shows a services-heavy business with IFRS-reported revenues of $20,158M in FY26 vs $19,277M in FY25 — roughly 4.6% growth. Operating profit was $4,085M (20.3% margin) vs $4,071M (21.1%) — margins slightly compressing but not collapsing. Critically, the narrative states free cash flow is positive and that Infosys returned ~85% of FCF to shareholders via dividends/buybacks (~$1B+ quarterly), with $3.9B cash on hand and a debt-free balance sheet. The DCF block flags 'negative or missing FCF,' but this appears to be a data ingestion issue (the filing and narrative explicitly reference positive FCF and the capital return policy tied to it); I cannot confirm the exact FCF figure from the excerpts, so I note this uncertainty rather than asserting a number. On earnings quality: the fact base does not expose a persistent gap between net income and operating cash flow across 8-12 quarters — that data is absent, so I cannot confirm clean earnings quality either, but there are no red flags surfacing from the filing excerpts. Revenue recognition: Infosys books IT services under IFRS 15, with fixed-price and time-and-materials contracts. The 20-F notes complexity in percentage-of-completion judgments and multi-element arrangements, which are standard areas of subjectivity but not evidence of manipulation. No mention of unusual unbilled receivables growth, channel stuffing, or related-party revenue. DSO trends are not quantified in the excerpts available. Working capital: no evidence of receivables or inventory growing faster than revenue in the excerpts. SBC/dilution: the 6-K on KMP stock incentives is routine disclosure; shares outstanding (4.15B) and buyback activity (₹18,000 Cr approved in Sep 2025 per 20-F) suggest buybacks are material — but the narrative does not indicate the share count is rising. Management commentary acknowledges organic growth has stalled (~0.8% ex-acquisitions in FY27 guidance), which is a fundamental concern but not an accounting fraud red flag. Governance: no auditor changes, no restatements, no going-concern language, no CFO turnover flagged (CFO Jayesh Sanghrajka signed the 6-K). CEO transition to Ashish Dash is planned and orderly. The McCamish cybersecurity incident (noted in 20-F FY25) and a $119M contingent liability cluster are manageable. AI revenue opacity (8.2% 'AI-first' per narrative) is a disclosure quality issue but not fraud. The main forensic concern is the 'AI deflation' dynamic compressing ACVs at renewals — this is a real structural headwind that could cause revenue to disappoint against reported large-deal TCV, but it is acknowledged rather than hidden. OVERALL: This is a modestly growing, cash-generative, dividend-paying IT services company with some margin pressure and guidance cuts. It is not a forensic short candidate. The pass score reflects absence of red flags, not a ringing endorsement of the business outlook.

Key points

• 20-F FY26 shows $20,158M revenue, $4,085M operating profit (20.3% margin) — no collapse in reported financials
• Capital return policy explicitly tied to ~85% of free cash flow, with $3.9B cash and no debt per narrative — financing dependence risk is minimal
• Buyback of ₹18,000 Cr approved (20-F FY26) alongside >$1B dividends — management returning cash, consistent with positive FCF
• No auditor changes, restatements, going-concern language, or CFO turnover in the available filings
• Revenue recognition complexity noted (IFRS 15 multi-element, fixed-price) but no evidence of unusual unbilled receivables or aggressive pull-forward
• McCamish cybersecurity liability and $119M contingent claims (20-F FY25) are disclosed and quantified — not hidden
• CEO transition orderly; Parekh to Dash with 6-month mentorship overlap, not a sudden departure
• AI revenue growth (8.2% of total) is a real and growing line — not a fabricated narrative metric, but disclosure of margin profile is thin

Red flags

• DCF block flags 'negative or missing FCF' — this conflicts with management's explicit FCF-linked capital return policy; the discrepancy needs resolution but may be a data ingestion artifact rather than an accounting issue
• 'AI deflation' at renewals compresses ACVs but management declines to quantify — creates a gap between large-deal TCV announcements and actual revenue that could mislead investors on booking quality
• Organic growth ~0.8% ex-acquisitions in FY27 guidance while acquisitions (Optum Health, Tastus) contribute ~170 bps — acquisition-dependent growth warrants scrutiny of earn-out terms and integration costs, which are not detailed in the available excerpts
• AI revenue definition ('AI-first hexagon') is internally constructed and not audited separately — opacity around whether this is a genuine segment or a marketing reframe
• DSO trends and unbilled receivables balances are not available in the filing excerpts provided — cannot fully clear the receivables-growth-vs-revenue test
• SBC as percentage of adjusted profit not quantified from available excerpts — cannot fully test treadmill dilution

Warren Buffett — 🟡 watch · 58/100 · medium confidence

Infosys is an established, profitable, large-scale IT services business with a long operating history, understandable economics, and consistent free cash flow generation — clearly within a circle of competence as a global technology services outsourcer. However, from a Buffett quality lens, the key question is whether it possesses a durable economic moat with pricing power, and here the evidence is mixed to concerning. The 20-F (fiscal 2026) shows operating margins declining from 21.1% to 20.3% year-on-year, and the narrative from the Q1 FY27 earnings call explicitly describes 'AI-led deflation' — clients demanding productivity-linked price reductions at contract renewals. This is the antithesis of pricing power. Revenue growth guidance was cut sharply to 1.5–3% YoY (with organic growth of only ~0.8%), suggesting the business is essentially stagnating in volume terms while simultaneously giving back price. On the positive side: the 20-F confirms revenues of $20.2B in fiscal 2026 vs. $19.3B in fiscal 2025, showing consistent top-line growth over multiple years ($18.2B in FY2023, $18.6B in FY2024, $19.3B in FY2025, $20.2B in FY2026 per the 20-F export revenue data). The capital allocation policy — returning ~85% of free cash flow via dividends and buybacks — is shareholder-friendly and rational. The board recommended a final dividend of ₹25/share for FY2026 (per the 20-F filed 2026-06-15), and a ₹18,000 crore buyback was approved. The balance sheet appears conservative: the narrative describes the company as 'debt-free with $3.9B cash.' However, the ROE data is flagged as null in the fundamentals block, so I cannot confirm the sustained 15%+ ROE criterion from this fact base — a meaningful gap in evidence. The DCF is flagged as not applicable due to negative/missing FCF data in the valuation block, which is inconsistent with the narrative's reference to strong cash generation; this may reflect a data/currency mismatch (INR vs. USD) rather than true negative FCF, but I cannot confirm a specific owner-earnings figure from the filings provided. On AI disruption: this is the central tension. Infosys is attempting to ride the AI wave (8.2% of revenue, growing double-digit sequentially per the earnings call), but the same AI is compressing pricing on legacy services. The 'Topaz Fabric' platform and frontier engineer program are real investments, but IT services businesses historically lack the switching-cost moat of a consumer brand or software platform — clients can, and do, reprice at renewal. The CEO transition (Salil Parekh departing March 2027, per the narrative) introduces management continuity risk. Parekh presided over revenue growth from ~$10B to ~$20B; his successor Ashish Dash is unproven at the top. For Buffett criteria: the business is understandable and profitable, capital allocation is shareholder-friendly, balance sheet appears sound, but pricing power erosion is a structural red flag, organic growth has effectively stalled, ROE cannot be confirmed, and the DCF cannot be run. This is a 'watch' rather than 'pass' — a good business in a structurally pressured competitive position, not the 'wonderful company at a fair price' standard I require.

Key points

• Consistent revenue growth over 4 years per 20-F: $18.2B (FY23) → $18.6B (FY24) → $19.3B (FY25) → $20.2B (FY26), demonstrating an established, growing enterprise
• Capital allocation explicitly shareholder-friendly: ~85% FCF return policy confirmed in both 20-F filings (2026-06-15 and 2025-07-01); ₹25/share final dividend and ₹18,000 crore buyback approved for FY2026
• Operating margins relatively stable in the 20–21% range (20.3% in FY26 vs. 21.1% in FY25 per the 20-F), with management guiding 20–22% for FY27 — not spectacular but consistent
• Debt-free balance sheet with ~$3.9B cash per narrative; conservative financial structure aligns with Buffett preference for self-funding through downturns
• Large-deal momentum ($3.6B wins, 61% net new per earnings call) shows ongoing client demand, and AI revenue at 8.2% of total growing sequentially provides some evidence of adaptation

Red flags

• Explicit pricing power erosion: earnings call describes 'AI-led deflation' at contract renewals — clients demanding productivity-linked price reductions, the opposite of a moat with pricing power
• Organic revenue growth collapsed to ~0.8% ex-acquisitions (per narrative on FY27 guidance), suggesting the core business is barely growing in volume terms
• Operating margin declined from 21.1% to 20.3% YoY (20-F filed 2026-06-15), and Q1 FY27 pressures include wage hikes, acquisition amortization drag, and AI sales investment headwinds
• ROE data is null in the fundamentals block — cannot confirm sustained 15%+ ROE requirement from available evidence; this is a critical missing data point
• DCF flagged as not applicable in the valuation block; cannot independently confirm owner-earnings quality or margin of safety from this fact base
• CEO succession risk: Salil Parekh departs March 2027 (per narrative), replaced by Ashish Dash who has no prior CEO track record — management continuity uncertainty at a critical competitive inflection
• IT services lacks strong switching-cost moat at contract renewal; hyperscalers (AWS, Azure, Google) entering services space (per earnings call) and competitive intensity explicitly rising per analyst downgrades (JPMorgan Neutral $10.90, HSBC Hold)

Valuation Referee (Damodaran-style) — 🟡 watch · 58/100 · medium confidence

Infosys is a mature, large-cap IT services company with a long operating history, IFRS financials, and enough disclosed fundamentals to build a story-to-numbers DCF. The DCF block in the fact base is flagged 'not applicable' due to negative or missing FCF, which is puzzling given management commentary describes free cash flow generation (capital allocation policy targets 85% FCF return, and the narrative cites 'free cash flow +16.5% of net profit' and '$3.9B cash'). The negative FCF flag likely reflects a data extraction issue rather than a genuine negative FCF business — Infosys is not a cash-burning startup. I will therefore construct an implied-expectations analysis from the available disclosures rather than rely on the DCF block.

Revenue base and growth: 20-F (filed 2026-06-15) discloses FY2026 total revenues of $20,158M vs. FY2025 $19,277M, implying ~4.6% reported growth. However, Q1 FY27 guidance was revised sharply downward to 1.5–3% YoY (constant currency), with organic growth of only ~0.8% ex-acquisitions (per narrative). This is a material deceleration.

Operating margin: The 20-F reports FY2026 reported operating margin of 20.3% vs. 21.1% in FY2025 — a 80 bps compression. Management guides 20–22% for FY27 (Q1 FY27 came in at 21.1% per narrative). Margin stability is plausible but not expanding.

Implied expectations from price: At $11.67/ADS (USD), with ~4.15B shares and market cap ~$48.5B, applying a rough P/E of ~22–24x (consistent with an IT services business growing low-single digits) implies earnings of ~$2–2.2B, which is broadly consistent with a 20–21% operating margin on $20B revenue after tax at ~25%. So the market is pricing roughly a stable, low-growth IT services business — not a high-growth platform. Reversing: to justify $11.67 at a 10% WACC (appropriate for an Indian IT exporter — USD revenues, INR costs, moderate beta of 0.79 per fundamentals, but country risk premium applies), assuming terminal growth of 3–3.5% (reasonable for a global IT services firm with India base), the market needs roughly 5–7% medium-term revenue growth and stable ~21% EBIT margins. At the guided 1.5–3% growth, the current price looks roughly fair-to-slightly-expensive, not a bargain.

ROIC vs. WACC: Infosys historically generates high returns on invested capital — IT services companies are capital-light. The 20-F confirms CSR spending of $70M and capital allocation returning ~85% of FCF. But with organic growth near 0.8% and acquisitions providing the rest, the incremental ROIC question is: what are Optum Health and Tastus acquisitions returning? No ROIC data on acquisitions is available in the fact base. This is a gap.

AI deflation risk as a narrative-number disconnect: The narrative (bull) says AI revenue is 8.2% of total and growing double-digit sequentially. But the bear case — and management acknowledges it — is that AI is also causing pricing deflation in the remaining ~92% of revenue as clients demand productivity pass-throughs at renewal. This creates a story-numbers tension: the AI growth story is real, but its net contribution to value may be muted if it cannibalizes legacy margins. Management refuses to quantify the net deflation impact, which is a transparency gap for DCF purposes.

Terminal value concerns: If organic growth is ~0.8% today and AI deflation compresses renewal ACVs, assuming reversion to 5–6% medium-term growth (what current price implies) requires the AI transition to accelerate meaningfully. This is possible but not certain — it's the optimistic scenario, not the base case.

Margin of safety: The stock has already surged ~16% post-earnings per the narrative, suggesting sentiment cleared but bargain-hunting opportunity diminished. At current price, the investment works only if growth recovers to the 5%+ range — not guaranteed given the guidance cut.

AI/tech disruption: Infosys faces a dual dynamic — AI is both opportunity (8.2% revenue, growing fast) and threat (client productivity demands, hyperscaler competition). From a valuation frame, the DCF value is sensitive to whether AI deflation is a 50 bps headwind or a 200+ bps structural margin compressor. This uncertainty warrants a wider WACC range in any sensitivity, adding to 'watch' rather than 'pass' disposition.

Bottom line: Infosys is not obviously cheap. The price implies growth recovery assumptions (~5%+ medium term) that are above current guidance (1.5–3%) and above current organic reality (~0.8%). Margins are stable but not expanding. The business is high-quality and capital-light, but the price does not offer a margin of safety under conservative-but-fair assumptions. A clear buy would require either a price ~10–15% lower or evidence of sustained growth reacceleration. Score: 58 — a Watch.

Key points

• FY2026 revenue $20,158M per 20-F (filed 2026-06-15), growing ~4.6% YoY; but FY27 guidance cut to 1.5–3% constant currency with organic growth ~0.8% ex-acquisitions (per narrative)
• Operating margin 20.3% in FY2026 vs. 21.1% in FY2025 per 20-F; Q1 FY27 at 21.1% per narrative; management guides 20–22% for full FY27 — stability but no expansion
• At ~$48.5B market cap and ~$11.67/ADS, current price implies ~5–7% medium-term revenue growth recovery to be justified at 10% WACC with 3% terminal growth — above current guidance/organic reality
• Capital allocation policy targets ~85% of FCF returned (dividends + buybacks) per 20-F (2026-06-15); $3.9B cash on balance sheet per narrative — strong financial health
• AI revenue at 8.2% of total, growing double-digit sequentially (per narrative/earnings call), is a genuine growth vector but creates AI deflation headwind on renewal pricing for the remaining ~92%
• DCF block flagged non-applicable (negative/missing FCF in data extraction) but appears to be a data issue, not a genuine cash-burn situation — FCF is real per capital allocation disclosures
• Buyback of ₹18,000 crore approved (per 20-F 2026-06-15); final dividend ₹25/share recommended — returns are substantial but represent capital discipline more than undervaluation signal
• CEO transition (Parekh → Dash, Mar 2027) adds execution uncertainty in a transformational period — a DCF discount-rate consideration

Red flags

• Price implies ~5–7% medium-term growth recovery; current guidance (1.5–3%) and organic reality (~0.8%) are well below this implied expectation — limited margin of safety
• AI deflation effect on renewal pricing is acknowledged but unquantified by management — creates a material story-to-numbers gap that undermines DCF precision
• Acquisition ROIC unverifiable: Optum Health and Tastus integration economics not disclosed in the fact base — value-creation vs. value-destruction question open
• Post-earnings stock surge ~16% (per narrative) has likely priced in sentiment recovery; bargain-buying opportunity may have passed before this analysis
• DCF block non-applicable flag creates data quality concern — intrinsic value cannot be anchored on the provided model; independent construction required with limited data
• Operating margin compressed 80 bps YoY (FY26 vs FY25 per 20-F) while revenue growth slowed — cost efficiency not fully offsetting revenue mix headwinds
• CEO succession to an unproven C-suite leader in the AI transformation era adds WACC-relevant execution risk not reflected in the stock's current low beta (0.79)

Charlie Munger — 🟡 watch · 58/100 · medium confidence

Infosys is a large, understandable, asset-light IT services business with a three-decade operating history — squarely within a definable circle of competence. The business model is simple enough to explain in a paragraph: Infosys sells technology services and outsourcing to large global enterprises, earning a spread between what clients pay and what it costs to deploy skilled labor. What I care about is whether the moat is durable and whether the returns on capital justify a long hold. On the positive side, the company has operated at ~20% operating margins for years, carries a debt-free balance sheet with $3.9B in cash (per the narrative), returns ~85% of free cash flow to shareholders through dividends and buybacks (20-F filed 2026-06-15 confirms this capital allocation policy), and has genuine switching costs embedded in deep, multi-year client relationships. The $3.6B in large-deal wins with 61% net-new per the earnings commentary shows the franchise is still winning new mandates. Operating margins held at 21.1% in Q1 FY27 despite real headwinds — that is a sign of cost discipline. The dividend policy is rational and owner-minded: the Board recommended ₹25 per share final dividend for FY26, and the company executed an ₹18,000 crore buyback approved by shareholders (20-F filed 2026-06-15). These are honest, shareholder-friendly acts. However, several Munger-style concerns temper enthusiasm. First, the moat is eroding at the margin. IT outsourcing is increasingly commoditized — pricing power is visibly weakening, with management explicitly acknowledging 'AI-led deflation' at renewals and clients demanding productivity concessions. A true wide-moat business does not need to explain why its customers are extracting concessions. Second, organic growth has stalled at approximately 0.8% for FY27 (per narrative, revenue guidance of 1.5–3% includes ~1.7% from acquisitions). A business with genuine reinvestment advantages should compound intrinsic value per share, not stagnate. Third, AI is simultaneously an opportunity and an existential threat to the labor-arbitrage model that underlies Infosys's economics. Management is positioning AI revenue at 8.2% of total and growing, which is encouraging, but the rest of the portfolio faces deflationary pressure from the same technology. The net effect on owner earnings over a 5–10 year horizon is genuinely uncertain. Fourth, the DCF is flagged as not applicable due to negative or missing FCF data in this fact base — this is a data gap I cannot ignore. The 20-F confirms a capital allocation policy pegged to free cash flow, implying FCF is positive, but the valuation block cannot confirm or size it from the available data. Fifth, the CEO transition (Salil Parekh departing March 2027, Ashish Dash as designate) introduces real uncertainty. Management quality matters enormously in a services business where talent and client relationships are the assets. On valuation: the price data in this fact base is confused (ADS price $11.67 vs. 52-week high of 1,728 suggesting INR/USD mixing), making a precise FCF yield calculation impossible from available data. At a market cap of approximately $48.5B USD and revenues of roughly $20B USD (20-F FY26), the stock trades at roughly 2.4x sales — not obviously cheap for a low-single-digit growth business. Inversion test: what kills this permanently? AI wholesale disruption of labor-arbitrage outsourcing is the primary risk. It is not zero-probability over a 10-year horizon. That said, Infosys is not a cigar butt — it generates real cash, has real client relationships, and is actively investing in the AI transition. It is a business in a quality range I would watch rather than avoid, but I would not pay up for it at current levels until organic growth and pricing dynamics stabilize and the AI revenue mix becomes large enough to offset legacy deflation. The quality is real but the moat is narrowing, and the reinvestment opportunity at high incremental returns is less clear than I would demand for a full position.

Key points

• Debt-free balance sheet with $3.9B cash and 85% FCF return policy per 20-F (2026-06-15) — genuinely owner-minded capital allocation
• Operating margins sustained at ~20–21% across cycles demonstrates real cost discipline and some pricing floor
• $3.6B large-deal wins, 61% net-new per Q1 FY27 earnings, showing franchise is still relevant to large enterprise buyers
• AI revenue at 8.2% of total and growing double-digit sequentially — real optionality if transition succeeds at scale
• Switching costs from multi-year, deeply embedded client relationships provide some moat durability
• Simple, understandable business model — well within circle of competence; no accounting black boxes in evidence from filings reviewed
• Capital allocation rational: ₹18,000 crore buyback (20-F 2026-06-15) and progressive dividend policy

Red flags

• Organic growth ~0.8% for FY27 — a business with a durable moat and high reinvestment returns should not stagnate
• AI deflation explicitly acknowledged by management at contract renewals — pricing power is weakening, which is a moat warning sign
• DCF flagged not applicable in fact base due to missing/negative FCF — cannot verify owner earnings yield from available data
• CEO transition March 2027 introduces management quality uncertainty in a talent-dependent services business
• Competitive intensity rising from both traditional peers and hyperscalers (AWS, Azure, Google) entering services
• Acquisition drag from Optum Health and Tastus (50 bps margin impact, per narrative) with integration opacity — risk of capital misallocation
• 52-week price data appears to mix INR and USD figures, creating valuation ambiguity in this fact base that cannot be resolved without external data

Chuck Akre — 🟡 watch · 55/100 · medium confidence

Infosys is a large-cap IT services franchise with genuine capital-light characteristics — asset-light delivery model, strong cash generation historically, and recurring client relationships that provide switching-cost moats. However, against my three-legged stool test, I find meaningful problems with at least two legs: the reinvestment runway and management quality/capital allocation. Let me work through each leg carefully using the fact base.

Leg 1 — Extraordinary Business: Partially present. The 20-F (filed 2026-06-15) shows operating profit margin of 20.3% for fiscal 2026 vs. 21.1% in fiscal 2025 — declining but still respectable for a services business. Total revenues grew from $18,562M (FY2024) to $19,277M (FY2025) to $20,158M (FY2026), showing steady but unspectacular top-line progression. The business is genuinely capital-light: IT services don't require heavy physical plant. The AI revenue stream (8.2% of total per the earnings call narrative, growing double-digit sequentially) is a real positive signal. However, the moat quality is contested — management explicitly acknowledged on the Q1 FY27 call that AI-led 'deflation' is compressing pricing at renewals, suggesting the switching costs and pricing power are eroding at the margin. This is a yellow flag for franchise durability.

Leg 2 — Management Skill & Integrity: Mixed. On the positive side, the capital allocation policy (20-F, 2026-06-15) commits to returning ~85% of free cash flow over a 5-year period via dividends and buybacks — disciplined and shareholder-friendly. The Board approved a final dividend of ₹25/share for FY2026 and a buyback of ₹18,000 crore (approved September 2025), showing active capital return. However, there are concerns: (a) Salil Parekh's departure (31 Mar 2027) creates a leadership vacuum at a transformational moment — Ashish Dash is untested in the CEO role; (b) the FY27 guidance was cut from ~2.5% to 1.5–3% midpoint within one quarter, raising questions about management's visibility and forecasting credibility; (c) acquisitions (Optum Health, Tastus) are described in the narrative as creating 50 bps margin drag from intangibles amortization and retention costs, but integration details and earn-out terms are opaque in the available fact base — I cannot verify whether these were value-accretive at the prices paid. The 20-F discusses related-party transactions but directs readers to Note 2.20 without providing the full text — I cannot flag specifics but note the opacity.

Leg 3 — Reinvestment Runway: This is the weakest leg. Organic growth in FY27 is approximately 0.8% (ex-acquisitions per the narrative), essentially a stall. The narrative notes the guidance cut implies near-stagnation organically. For a compounder, the ability to reinvest free cash flow back into the business at high incremental returns is paramount — but if the core IT services market is mature and AI is simultaneously deflating pricing, the reinvestment opportunity at high ROICs is questionable. The DCF is flagged as 'not applicable' due to negative or missing FCF in the valuation block — this is a significant data gap; historically Infosys has had positive FCF (the 20-F references free cash flow in the capital allocation policy context), so this flag likely reflects a data issue rather than a true FCF-negative business, but I cannot confirm without the full cash flow statement numbers. The narrative mentions FCF +16.5% of net profit in Q1, which seems low — this needs verification.

AI & Disruption Assessment: AI is a dual-edged sword here. Infosys is building AI revenues (8.2% of total) and investing in frontier engineers and Topaz Fabric platform — genuine offensive moves. But the defensive risk is acute: hyperscalers entering services, AI automating the coding/maintenance work that comprises much of Infosys's bread-and-butter, and clients demanding productivity deflation on renewals. Over a 3–10 year horizon, AI could significantly compress the unit economics of traditional IT services. Infosys's large headcount (300k+) is simultaneously an asset (client context, delivery scale) and a liability (labor-intensive cost base in an AI-automation world). I view this as net-negative for the franchise quality leg over a 10-year horizon unless AI revenue scaling continues at its current pace.

Valuation: The price data is confusing — the fact base shows last_close of $11.67 USD (ADS price) but 52-week high/low of 1728/982 (INR on NSE). At ~$48B market cap and revenues of ~$20B, the P/S is roughly 2.4x. Operating margins of ~20% suggest operating income of ~$4B, implying a rough P/EBIT of ~12x — not expensive for a quality franchise, and the narrative references post-earnings stock surge of ~16% suggesting it was oversold. The DCF is flagged not applicable, so I cannot use the two-stage model. At these levels, the price is reasonable — not a bargain, not overvalued — but 'reasonable' only matters if the compounding machine is intact, which I doubt.

Summary: Two legs of the stool (extraordinary business, management integrity/skill) are partially present but weakened. The reinvestment runway — my most important leg — is severely compressed by near-zero organic growth, AI deflation risk, and a maturing market. The business is too good to call an avoid, but too impaired on the compounding runway to call a pass. Watch it.

Key points

• Capital-light IT services model with ~20.3% operating margins (20-F, FY2026) — decent franchise economics but declining from 21.1% in FY2025
• Revenue has grown steadily: $18.6B (FY2024) → $19.3B (FY2025) → $20.2B (FY2026) per 20-F filed 2026-06-15, but organic FY27 growth is ~0.8% ex-acquisitions per earnings call narrative
• Capital allocation policy (20-F, 2026-06-15) commits to returning ~85% of FCF over 5 years; ₹18,000 crore buyback approved Sep 2025; ₹25/share final dividend for FY2026 — shareholder-friendly actions
• AI revenue at 8.2% of total, growing double-digit sequentially per Q1 FY27 earnings call — this is the most important compounding opportunity to monitor
• $3.6B in large-deal wins with 61% net new (per narrative/earnings call) shows the business is winning in the market, but deal ACVs are compressed due to AI-productivity deflation at renewals
• Balance sheet described as debt-free with $3.9B cash (per narrative) — no leverage-driven ROE concern, which is consistent with my quality screen
• CEO succession to untested Ashish Dash (Mar 2027) and FY27 guidance cut within one quarter raise management credibility concerns

Red flags

• Reinvestment runway severely compressed: organic FY27 growth ~0.8% (narrative) — hard to compound per-share intrinsic value at high rates with near-zero organic growth
• AI deflation risk: management explicitly acknowledged on Q1 FY27 call that pricing at renewals is being compressed by AI-productivity demands — this threatens the pricing power leg of the franchise moat
• DCF flagged as 'not applicable' due to negative/missing FCF in the valuation block — data gap prevents full FCF compounding analysis; I cannot confirm FCF per share trajectory
• Acquisition integration opacity: Optum Health and Tastus creating 50 bps margin drag; earn-out terms and value-accretion case not verifiable from available fact base — potential management capital allocation concern
• Leadership transition risk: Salil Parekh departs Mar 2027; Ashish Dash unproven as CEO; 6-month mentorship overlap is short for a $20B enterprise at an AI inflection point
• Guidance credibility: FY27 CC growth guidance cut from ~2.5% midpoint to 1.5–3% within one quarter — raises questions about management visibility and honest communication with shareholders
• Hyperscaler competition (AWS, Azure, Google entering services) and AI automation of coding/maintenance work pose structural 3–10 year threat to core IT services economics — the compounding runway may be shorter than it appears

Joel Greenblatt — 🟡 watch · 55/100 · medium confidence

Infosys is a profitable, operating IT services business with measurable EBIT and a tangible capital base — the Magic Formula lens is applicable. However, the fact base is thin on the precise ROIC calculation inputs (net working capital, net fixed assets in dollar terms from the most recent filing), and the DCF is flagged not-applicable due to negative/missing FCF in the valuation block, which is a data anomaly given management commentary explicitly references 'free cash flow +16.5% of net profit' and a $3.9B cash balance. I must flag this gap rather than fabricate numbers.

What the fact base does support: From the 20-F filed 2026-06-15 (period ending March 31, 2026), Infosys generated $20,158M in total revenue and $4,085M in reported operating profit (EBIT), representing a 20.3% operating margin. That is a strong, real EBIT — not distorted by financial engineering. The narrative confirms Q1 FY27 operating margin of 21.1%, with the company maintaining 20–22% guidance. These are genuine operating margins for a large-scale IT services business, which is encouraging.

On ROIC (Greenblatt denominator = EBIT / (net working capital + net fixed assets)): IT services companies like Infosys are famously asset-light. The fixed-asset base is modest relative to revenue (campuses, leasehold improvements, computers), and working capital is moderate. This structural asset-lightness historically yields very high ROIC by Greenblatt's formula — potentially 40-80%+ — but I cannot compute a precise figure because the fact base does not excerpt balance sheet line items (net fixed assets, current assets, current liabilities) in enough detail for me to verify. I note this as a missing-data flag. Based on sector knowledge of IT services economics, ROIC is likely strong, but I will not assert a specific number I cannot trace to this fact base.

On earnings yield (EBIT/EV): Market cap is stated as $48.45B USD (narrative confirms ADS price × shares). The narrative references a debt-free balance sheet with $3.9B cash, implying EV ≈ $48.45B - $3.9B = ~$44.6B (assuming no material debt or minority interest disclosed in this fact base). With annualized EBIT of roughly $4.1B (FY2026 20-F), EBIT/EV ≈ $4.1B / $44.6B ≈ 9.2%. That is a respectable — but not cheap — earnings yield by Greenblatt standards; the Magic Formula historically rewards yields of 12%+ to rank highly. At ~9%, Infosys is fairly valued on this axis, not a screaming bargain.

Magic Formula ranking synthesis: Strong ROIC (asset-light IT services, likely high) but moderate earnings yield (~9%) means this is a 'good business at a fair price' — exactly the territory Greenblatt says Buffett inhabits but which his own formula typically does not favor unless the yield is higher. The stock is not cheap enough to rank highly on the earnings-yield screen even though the business quality is solid.

Growth and AI dynamics: The narrative (6-K, July 2026 earnings call) reveals organic growth of only ~0.8% YoY (ex-acquisitions), a cut guidance to 1.5–3%, and AI deflation compressing renewal ACVs. From a Greenblatt perspective, stalling organic growth is a meaningful concern because it suggests normalized EBIT may not grow, making current earnings the ceiling rather than a trough. This reduces the 'good business compounding for me' benefit. The AI revenue (8.2% of total, growing rapidly per narrative) is a genuine bright spot but its margin profile vs. legacy work is unquantified in the filings.

Capital allocation: The 20-F (2026-06-15) confirms a policy of returning ~85% of free cash flow over 5 years via dividends/buybacks. Final dividend of ₹25/share recommended for FY2026, implying ~$1.07B cash outflow. A ₹18,000 crore (~$2.1B) buyback was approved per the 20-F. This is genuinely shareholder-friendly capital allocation — a Greenblatt positive.

Special situations: No spinoff, restructuring, or forced-selling catalyst is present. The CEO transition (Parekh → Dash, March 2027) is a leadership event but not a value-unlocking special situation in the Greenblatt sense. No institutional neglect discount is evident — Infosys is a widely followed, large-cap ADR.

AI disruption assessment: The earnings call transcript (via narrative) reveals a nuanced picture. AI is both a growth engine (8.2% of revenues, double-digit sequential growth) and a deflationary force on legacy contracts. Clients are demanding AI-led productivity concessions at renewals. Infosys's 300k-person headcount and Topaz Fabric platform position it as an enabler rather than a pure victim, but the risk that hyperscalers (AWS, Azure, Google) build competing services arms is real and explicitly noted. From a Greenblatt lens, this means the moat on ROIC could be narrowing — the intangible advantage of large-scale IT delivery could be partially commoditized, which would compress the sustainable ROIC over a 5-10 year horizon. This is a watch-level concern, not an immediate avoid.

Summary: Good business (likely high ROIC), fair price (not cheap enough on earnings yield at ~9%), no special-situation catalyst, mild organic growth stall, and AI deflation risk on legacy revenues. This is a 'watch' — revisit if stock dips to earnings yield of 12%+ (roughly $34B EV, implying stock price ~$8-9 ADS) or if organic growth accelerates.

Key points

• FY2026 EBIT of $4,085M on $20,158M revenue (20-F filed 2026-06-15) — 20.3% operating margin, real and repeatable, not distorted by one-offs
• Estimated EBIT/EV ~9.2% ($4.1B EBIT / ~$44.6B EV using $48.45B market cap minus $3.9B net cash per narrative) — fair but not cheap on Greenblatt's earnings yield screen
• Asset-light IT services model implies very high ROIC on Greenblatt's tangible capital denominator — this is likely the strongest Magic Formula input, but precise balance sheet breakout not available in excerpted filings
• Capital allocation is genuinely shareholder-friendly: 85% FCF return policy, ~$1.07B dividend outflow, ~$2.1B buyback approved (per 20-F 2026-06-15)
• AI revenue at 8.2% of total growing double-digit sequentially per Q1 FY27 earnings call (narrative) — genuine growth vector offsetting legacy softness
• Organic growth only ~0.8% YoY ex-acquisitions per narrative — near-stall undermines the 'high-ROIC compounder' thesis that makes a fair price acceptable

Red flags

• Earnings yield ~9% is respectable but insufficient to rank highly in Greenblatt's Magic Formula screen — the stock is fairly priced, not cheap
• Organic growth stall (0.8% ex-acquisitions) means normalized EBIT may be flat, reducing compounding benefit and making current multiples less attractive
• AI deflation risk: management acknowledges clients demanding productivity concessions at renewals, compressing ACVs — could structurally erode EBIT margins over time (unquantified per narrative)
• No special-situation catalyst (spinoff, restructuring, forced selling) — this is a plain-vanilla large-cap ADR, not a neglected or mispriced special situation
• CEO transition to unproven successor (Ashish Dash, March 2027) introduces execution risk in a transformational competitive period
• DCF flagged not-applicable in valuation block — inconsistent with management's FCF commentary; indicates data gaps in this fact base that reduce confidence in precise formula inputs
• Precise ROIC calculation not possible from excerpted filings — net working capital and net fixed assets not broken out in the fact base provided

Michael Mauboussin — 🟡 watch · 55/100 · medium confidence

Infosys presents a mixed picture through a Mauboussin quality/expectations lens. The company has genuine moat elements — meaningful switching costs rooted in deep client integration, some scale economies across a 300k+ headcount delivery machine, and a nascent AI platform (Topaz Fabric) — but the ROIC/WACC spread is neither wide nor clearly widening, and the expectations embedded in the current price require careful unpacking.

ROIC vs. WACC: The fact base does not provide explicit ROIC figures or WACC estimates, which is a material evidence gap I must flag rather than paper over. What we can infer: operating margins of ~20.3% in fiscal 2026 (20-F filed 2026-06-15), declining from 21.1% in fiscal 2025, in a capital-light services model. For an IT services business with minimal tangible capital intensity, operating margins in the 20% range typically translate to reasonably attractive ROICs — likely well above a WACC in the 9-11% range for a USD-denominated global company with 0.79 beta. But that spread is narrowing, not widening: margin compression from wage hikes, acquisition amortization drag, and AI deflation pressure at renewals is clearly documented in the narrative and filings. The direction matters as much as the level.

Moat Assessment — Narrow, Stable-to-Eroding:

• Switching costs (meaningful): Infosys is deeply embedded in core enterprise systems — banking platforms, ERP, application maintenance — where ripping out the vendor is costly in time, risk, and institutional knowledge. The 13% attrition rate and 300k headcount carrying client-specific context creates procedural and relational lock-in. This is the primary moat source.
• Scale economies (moderate): A global delivery model with offshore leverage creates real cost advantages vs. smaller peers, though not vs. TCS/Accenture. The 84.9% utilization rate (narrative) indicates the machine is running efficiently, but the model is inherently labor-elastic and does not exhibit the falling-unit-cost dynamics of software.
• Network effects (weak): IT services does not exhibit meaningful direct or indirect network effects. The Topaz Fabric platform could theoretically create data/ecosystem network effects, but this is embryonic — 8.2% of revenue labeled 'AI-first' (per narrative) tells us little about platform stickiness vs. project-based work.
• Intangibles (moderate): Infosys brand carries real weight in enterprise procurement decisions, and the Finacle/banking IP has genuine switching-cost-backed value. But brand does not confer pricing power here — the narrative explicitly flags pricing compression and 'AI deflation' at renewals, which is the opposite of brand-based pricing power.
• Moat trajectory: eroding at the margin. AI deflation is compressing ACVs at renewals. Hyperscalers entering services (AWS, Azure, Google) are structural, not cyclical. Organic revenue growth of ~0.8% (ex-acquisitions per narrative) is the most honest signal of competitive intensity.

Expectations Investing — What Does the Price Imply? At $11.67 USD (ADS price) with market cap ~$48.5B (fundamentals block), and fiscal 2026 revenues of $20.158B (20-F filed 2026-06-15), the stock trades at roughly 2.4x revenue. The DCF is flagged not-applicable due to negative/missing FCF in the valuation block, which is itself a yellow flag requiring investigation — the narrative references 'free cash flow +16.5% of net profit' and '$3.9B cash' suggesting FCF is positive; the DCF flag may reflect a data assembly issue rather than true negative FCF. Without a working DCF, I work backwards from multiples: at ~2.4x sales and ~20% operating margins, the implied P/EBIT is roughly 12x, which for a company with 1.5-3% revenue growth guidance (narrative) and margin pressure is not obviously cheap nor obviously expensive. The embedded expectation appears to be modest recovery — the market is not pricing a growth acceleration, but it is pricing margin stability. If margins compress to the 19% range on wage hikes + acquisition drag while organic growth stays sub-1%, the embedded expectations are too optimistic. Conversely, if AI revenue scales from 8.2% to 15%+ over 3 years as the digital analogy suggests (narrative), and carries better margins than legacy work, the current price embeds too little.

Distribution of Outcomes:

• Bull (25% probability): AI revenue compounds at 20%+ annually, reaching 15-18% of total by FY29; vendor consolidation wins accelerate; margins hold 21%+; multiple re-rates to 3x+ sales. Upside ~40-50% from current.
• Base (45% probability): Organic growth stays 1-3%, AI revenue grows but offsets legacy deflation rather than adding net, margins compress 50-100 bps from current levels as wage hikes and M&A drag hit H2 FY27; stock drifts +/- 10%. Leadership transition (Dash taking over Mar 2027 per narrative) introduces 6-12 months of uncertainty.
• Bear (30% probability): AI deflation accelerates legacy revenue erosion faster than AI gains grow, organic growth turns negative, margins fall below 19%, Dash transition disrupts client relationships or deal momentum. Multiple compresses to 1.8-2x sales; downside 25-35%.

Capital Allocation: The 85% FCF return policy (20-F filed 2026-06-15) is shareholder-friendly in principle. The ₹18,000 crore buyback approved (20-F filed 2026-06-15) and final dividend of ₹25/share (~$1.067B outflow per 20-F filed 2026-06-15) demonstrate commitment. However, the Optum Health and Tastus acquisitions introduce integration uncertainty and margin drag (50 bps per narrative) — it is too early to judge if these are ROIC-accretive. M&A in IT services has a mixed historical base rate.

AI/Disruption Assessment: This is the central question for Infosys. AI is simultaneously the company's stated growth engine (8.2% of revenue, growing) and its primary competitive threat (AI deflation compressing legacy contract ACVs). The honest read is that AI is a double-edged sword: it validates Infosys as a deployment partner for enterprise clients, but it also makes the labor arbitrage/headcount model less defensible over time. If hyperscalers successfully automate the work Infosys charges for, the switching cost moat weakens substantially. The 3-10 year horizon is genuinely uncertain — more so than management's confident 'digital analogy' framing suggests.

Evidence Gap: The fact base lacks explicit ROIC figures, segment-level margin data, and a working DCF. Confidence is accordingly medium rather than high.

Key points

• Operating margins of 20.3% in fiscal 2026 (20-F filed 2026-06-15) suggest a positive ROIC/WACC spread in a capital-light model, but the spread is narrowing year-over-year (from 21.1% in fiscal 2025)
• Primary moat source is customer switching costs from deep enterprise integration; scale economies are real but not exceptional; network effects are weak; brand does not currently confer pricing power given explicit AI deflation at renewals (narrative)
• At ~2.4x trailing sales, embedded expectations appear to price modest recovery — not demanding, but not a margin of safety if organic growth (0.8% ex-acquisitions per narrative) does not accelerate
• AI revenue at 8.2% of total growing double-digit sequentially (narrative) is a genuine optionality; the digital-to-AI analogy management cites has historical grounding but is not guaranteed to replicate
• Capital allocation policy (85% FCF return, $1B+ dividends, buyback approved) is disciplined; Optum Health/Tastus acquisitions are ROIC-uncertain and introduce drag (50 bps margin hit per narrative)
• CEO succession (Parekh to Dash, March 2027 per narrative) is a 6-12 month uncertainty window at a critical AI inflection point
• Outcome distribution is genuinely wide: AI deflation could accelerate or the AI revenue line could compound significantly — both tails are fat

Red flags

• Organic revenue growth of ~0.8% ex-acquisitions (per narrative) is essentially stall-speed for a company carrying a premium IT brand; base rate for ROIC mean-reversion at this growth level is high
• AI deflation explicitly compressing large-deal ACVs at renewals (narrative) — the moat's switching-cost component is being directly eroded by the technology clients are asking Infosys to implement
• DCF flagged not-applicable in valuation block due to negative/missing FCF — requires independent verification; if FCF is genuinely impaired, capital return sustainability is at risk
• Margin compression trajectory (20.3% vs 21.1% prior year per 20-F filed 2026-06-15) combined with upcoming wage hikes (H2 FY27 per narrative) and M&A amortization drag creates a multi-quarter headwind with limited offset clarity
• JPMorgan and HSBC analyst downgrades post-earnings call (narrative) suggest Street modeling same margin/growth concerns; consensus revision risk skewed negative near-term
• Acquisition integration (Optum Health, Tastus) is opaque — earn-out terms, margin profiles, and revenue synergies not disclosed in available fact base, making ROIC assessment of M&A impossible

Terry Smith (Fundsmith) — 🟡 watch · 55/100 · medium confidence

Infosys is a legitimate quality business — asset-light, high-margin IT services — but the fact base reveals enough friction on each of Smith's core tests to keep it at 'watch' rather than 'pass'. On the positive side: the 20-F (filed 2026-06-15) shows reported operating profit of $4,085M on revenues of $20,158M, implying a ~20.3% EBIT margin for fiscal 2026, and the company is demonstrably asset-light with a debt-free balance sheet and ~$3.9B in cash per the narrative. The capital allocation policy (20-F, fiscal 2026) commits to returning ~85% of free cash flow over a rolling 5-year period — a strong signal of cash generation discipline. The 85%+ FCF return policy also implicitly confirms strong cash conversion over time, even though the valuation block flags negative/missing FCF for this specific period (a data gap, not confirmed structural deterioration). However, Smith's tests are stressed by several findings. First, operating margin contracted from 21.1% to 20.3% YoY (20-F fiscal 2026), with management explicitly citing cost-of-sales, SG&A, and administrative cost increases — margin durability is under pressure, not stable. Second, the narrative reveals organic growth has nearly stalled (~0.8% ex-acquisitions for FY27), and management acknowledges 'AI-led deflation' at renewals, where clients extract productivity savings in pricing — a structural headwind to the moat's pricing power. Third, Infosys has executed debt-funded acquisitions (Optum Health, Tastus cited in the narrative), introducing ~50 bps margin drag from intangibles amortization and retention costs — Smith explicitly distrusts acquisitive growth, and the integration of these assets is opaque. Fourth, ROCE cannot be precisely computed from this fact base (debt-to-equity and current ratio are listed as null in fundamentals), but with operating margins declining and revenue growth near-stall, incremental returns on capital are unlikely to be improving. Fifth, the DCF is flagged not applicable due to negative/missing FCF — a direct red flag for Smith's cash-conversion test; even if this is a data artefact, the absence of a confirmable FCF yield means valuation on a cash basis cannot be verified. Sixth, AI deflation risk is real and unquantified: 8.2% of revenue is 'AI-first' growing rapidly, but it is compressing legacy pricing across the other ~92%. Smith would ask whether the moat is being hollowed out from within. The business remains high-quality relative to capital-intensive industries, and the balance sheet is clean, but the combination of margin compression, near-zero organic growth, acquisitive M&A drag, and unverifiable FCF makes this a 'watch' at current information levels rather than a conviction 'pass'.

Key points

• Operating margin 20.3% in fiscal 2026 vs 21.1% in fiscal 2025 (20-F filed 2026-06-15) — still respectable but directionally wrong for a quality compounder
• Debt-free balance sheet with ~$3.9B cash (narrative) — classic Smith balance-sheet preference satisfied
• 85% FCF return policy maintained (20-F fiscal 2026) — signals historically strong cash generation culture
• $3.6B in large-deal wins with 61% net new (narrative, earnings call) — demand franchise still intact at scale
• AI revenue at 8.2% of total and growing double-digit sequentially (narrative) — potential long-term reinvestment runway
• Utilization ex-trainees at 84.9%, up 190 bps QoQ (narrative) — operational efficiency improving at the margin
• Revenues grew from $18,562M (FY2024) to $20,158M (FY2026) per 20-F — steady absolute growth even if rate is decelerating

Red flags

• DCF flagged not applicable due to negative/missing FCF (valuation block) — cash conversion unverifiable from this fact base, Smith's most critical test
• Organic FY27 growth ~0.8% ex-acquisitions (narrative) — near-stall; a quality compounder should grow earnings reliably
• AI-led pricing deflation at renewals acknowledged but unquantified (narrative, earnings call) — structural threat to pricing power and moat integrity
• Acquisitions (Optum Health, Tastus) adding ~50 bps margin drag from intangibles amortization and retention costs (narrative) — Smith red flag: serial M&A masking true organic economics
• ROCE, debt-to-equity, and current ratio all listed as null in fundamentals block — critical return-on-capital metrics cannot be independently confirmed from this fact base
• Guidance cut to 1.5–3% FY27 growth from prior ~2.5% midpoint (narrative) — management credibility on forecasting weakened; April guidance already missed
• CEO transition risk: Salil Parekh departs March 2027; successor Ashish Dash unproven in C-suite (narrative) — uncertainty during an AI-inflection period

Ray Dalio — 🟡 watch · 52/100 · medium confidence

Infosys is a macro-relevant exposure for the Dalio framework, though it sits closer to the idiosyncratic compounder end of the spectrum than a classic macro cyclical. The lens applies because: (1) Infosys derives ~97% of revenues from exports outside India (per 20-F filed 2026-06-15: fiscal 2026 export revenues $19,582M of $20,158M total), making it a genuine USD-denominated global revenue stream with meaningful FX and geopolitical exposure; (2) its demand is deeply tied to corporate IT discretionary budgets, which are highly procyclical and credit-sensitive; (3) its balance sheet is debt-free with ~$3.9B cash (per narrative), conferring real resilience; and (4) the AI deflation dynamic creates a structural headwind that is partially regime-independent. Scoring it across the four Dalio boxes: RISING GROWTH / FALLING INFLATION (the 2010s 'Goldilocks' regime) — INFY thrives, corporate IT budgets expand, credit-funded digital transformation projects proliferate, margins healthy. Score: strong. RISING GROWTH / RISING INFLATION (boom/reflation) — mixed; IT budgets may hold but wage inflation hits hard (Infosys is a labor-intensive business, ~60-65% of revenue is employee cost implied by operating margin structure), clients may defer discretionary projects, currency impact ambiguous. Score: moderate. FALLING GROWTH / FALLING INFLATION (deflationary bust/deleveraging) — significant risk; corporate clients cut IT budgets sharply, deal cycles lengthen, pricing compresses further. The guidance cut to 1.5-3% YoY (per narrative, 24 Jul 2026) with organic growth ~0.8% is already consistent with early-stage demand softness that could worsen in a true deleveraging. Score: weak. FALLING GROWTH / RISING INFLATION (stagflation) — worst case for INFY; clients cut discretionary tech budgets while INFY faces persistent wage and operating cost inflation with limited pricing power (management acknowledges AI-led deflation at renewals per narrative earnings call). Score: very weak. This single-regime dependence (works best in Goldilocks) is a core Dalio red flag. BALANCE SHEET: Debt-free status and ~$3.9B cash (narrative) is the clearest positive. No maturity wall risk, no floating-rate refinancing exposure, strong interest coverage — this scores very well on the balance-sheet resilience criterion. Capital allocation policy returns ~85% of FCF over 5 years via dividends and buybacks (20-F 2026-06-15), which is shareholder-friendly but does mean the cash cushion is not being retained aggressively as a storm fund. RATE SENSITIVITY: Infosys itself has essentially zero direct rate sensitivity on its liability side (no material debt per filings). However, its customers — global enterprises, banks, manufacturers — are rate-sensitive. Higher-for-longer rates compress their capex/opex IT budgets. The FS/banking segment (5 large deals in Q1, per narrative) could face NIM pressure in a credit crunch. This indirect rate sensitivity is meaningful but manageable. INFLATION PASS-THROUGH: This is a structural weakness. IT services contracts are largely fixed-price or time-and-material with limited inflation escalators. Management explicitly acknowledged AI-led productivity deflation at renewals (narrative, earnings call). Wage inflation (Indian IT talent market, compounded by hyperscaler competition) is a cost push with limited offset. The 20-F 2026-06-15 notes Labour Code changes added $8M in gratuity/compensated absence costs in FY26. Operating margin already declined from 21.1% to 20.3% (20-F 2026-06-15) year-over-year. GEOGRAPHIC/FX DIVERSIFICATION: Revenue is genuinely global — US, Europe, rest of world segments. INR depreciation has been a tailwind (+70 bps to Q1 margin per narrative), which is a natural hedge on the cost base vs. USD revenues. However, ~97% export concentration means Infosys is essentially a play on global corporate IT demand, not a diversified multi-regime asset. All geographies cut IT budgets simultaneously in a global downturn — this is a correlation risk. DEBT CYCLE POSITION: Corporate IT discretionary spend was pulled forward aggressively during 2020-2022 (COVID digital acceleration). The current organic growth stall (0.8% per narrative) suggests normalization or mild hangover from that pulled-forward demand. Not at an extreme debt-cycle inflection, but the post-COVID digestion phase adds to near-term demand risk. AI DISRUPTION ASSESSMENT: The 8.2% AI revenue (up from 5.5% in Q3 FY26, per narrative) is real but the 'AI deflation' on legacy contracts is an existential dynamic — clients are demanding productivity pass-throughs in renewals, compressing ACVs. From a Dalio regime perspective, AI disruption is regime-independent risk: it compresses pricing in boom and bust alike. The Topaz Fabric platform and 6,000 frontier engineers are constructive but unproven at scale. If AI successfully transfers from 8.2% to 15-20% of revenue (management analog to digital, per narrative) it becomes a growth engine; if it primarily cannibalizes legacy margins, it accelerates structural decline. This uncertainty warrants a 'watch' not 'pass.' CORRELATION/DIVERSIFICATION VALUE: For a typical equity portfolio, INFY adds emerging-market IT services exposure with moderate beta (0.79 per fundamentals). It is reasonably uncorrelated to US domestics but highly correlated to global risk-on/risk-off — not a true diversifier in a Dalio All Weather sense. In a global equity selloff, INFY likely sells off with peers. DCF: Marked not applicable (negative/missing FCF per valuation block) — this is a gap in the fact base and somewhat surprising for a cash-generative business; the narrative references 'FCF +16.5% of net profit' and dividends >$1B, suggesting positive FCF. The DCF flag may reflect a data issue rather than actual negative FCF. Cannot rely on DCF for margin-of-safety assessment. Overall: Infosys is a high-quality, debt-free business with genuine global diversification and an AI growth option, but it is fundamentally a single-regime asset (Goldilocks dependent), faces structural AI deflation on its core book, and provides limited diversification value in a true risk-parity framework. The debt-free balance sheet prevents an 'avoid' rating; the regime dependence and pricing headwinds prevent a 'pass.'

Key points

• Debt-free balance sheet with ~$3.9B cash (narrative) and no maturity wall — strongest Dalio positive; passes balance-sheet resilience test decisively
• 97% of revenues are USD-denominated exports (20-F 2026-06-15: $19,582M of $20,158M), providing genuine FX hedge vs. INR cost base; INR depreciation added +70 bps to Q1 margin (narrative)
• Capital allocation policy returns ~85% of FCF over 5 years (20-F 2026-06-15), reducing balance sheet as a buffer but reflecting confidence in FCF generation
• AI revenue at 8.2% of total, growing double-digit sequentially (narrative) — genuine growth optionality that could be partially regime-independent
• $3.6B in large-deal wins with 61% net new (narrative) provides some visibility into near-term cash flows, reducing short-cycle demand risk
• Operating margin maintained at 20-22% guidance despite wage hike and acquisition headwinds (narrative), suggesting cost discipline

Red flags

• Single-regime dependence: Infosys thrives in Goldilocks (low rates, high growth, low inflation) but faces simultaneous demand contraction AND cost inflation in stagflation — the worst Dalio regime for this business
• AI deflation on legacy contracts: management explicitly acknowledges clients demanding productivity pass-throughs at renewals, compressing ACVs (narrative earnings call) — a pricing-power failure that is regime-independent
• Organic revenue growth of ~0.8% (narrative) — barely above stall speed; if a global demand contraction materializes, Infosys could see outright revenue declines given its discretionary IT spend exposure
• FY27 guidance cut to 1.5-3% (narrative) with acknowledged macro uncertainty — management has limited visibility, reducing confidence in through-cycle earnings forecasts
• Indirect rate sensitivity: global enterprise and banking clients face higher-for-longer rate pressure, which compresses their IT discretionary budgets (particularly relevant for FS/banking segment per narrative)
• Leadership transition risk (Parekh exits Mar 2027, Dash unproven as CEO) is idiosyncratic but adds uncertainty during a structurally difficult period
• DCF flagged not applicable in fact base — FCF data gap prevents quantitative margin-of-safety assessment under different regime assumptions
• High correlation to global risk-off: despite geographic diversification, all major INFY revenue geographies (US, Europe) cut IT budgets simultaneously in a global downturn — limited true diversification value

Philip Fisher — 🟡 watch · 52/100 · medium confidence

Infosys presents a mixed picture through a Fisher growth lens. The company has genuine long-term organic growth credentials — revenues have grown from $18.2B (FY24) to $20.2B (FY26) per the 20-F filed 2026-06-15, representing a mid-single-digit CAGR — but FY27 guidance of 1.5–3% YoY with organic growth implied at only ~0.8% (ex-acquisitions, per the earnings call narrative) signals a near-term stall that is deeply concerning for a Fisher investor who demands sustained, above-industry organic expansion. The AI revenue story (8.2% of total, growing double-digit sequentially per the earnings call narrative) is the most genuinely exciting element from a Fisher perspective — it echoes how digital went from ~20% to ~60% of revenue over years, and the Topaz Fabric platform and 6,000 frontier engineer program suggest real R&D-to-product conversion, not just marketing. However, the counter-narrative is troubling: AI is simultaneously driving 'deflation' in legacy contract renewals, compressing ACVs at renewals, and the magnitude is not disclosed. This is precisely the opacity Fisher flagged as a red flag — management acknowledges pricing pressure but refuses to quantify it. Operating margin of 21.1% in Q1 FY27 (20-F filed 2026-06-15 shows FY26 full-year at 20.3%) is respectable but not exceptional for the sector, and the 0.8% YoY decline (21.1% vs. 21.1% prior year FY26) shows margin pressure is real. Management candor receives mixed marks: the earnings call (per narrative) acknowledged headwinds including client termination, pricing compression, and offshoring shifts — that is Fisher-positive transparency — but the refusal to quantify AI deflation magnitude and vague macro assumptions ('improvement in macro baked into guidance') are Fisher-negative evasions. CEO succession is a genuine Fisher red flag: Salil Parekh built the modern Infosys, and Ashish Dash, despite 31-year tenure, is unproven at the CEO level during a transformational technology moment. Fisher abhorred one-man-band dependence, and the 6-month mentorship window for a $20B enterprise feels thin. The capital allocation policy — returning ~85% of FCF via dividends and buybacks (20-F filed 2026-06-15) — is antithetical to Fisher's compounding-internally preference; Fisher favored reinvestment over distributions when growth opportunities exist. $3.6B in large-deal wins (61% net new, per earnings narrative) and 20k college grad hires signal organizational scale and sales organization depth. But the headcount reduction of 500 net in Q1 and attrition at 13% suggest workforce management is steady, not exceptional. On AI disruption: this is the central tension. Infosys is both beneficiary (8.2% AI revenue, platform investments) and victim (AI deflation on legacy margins, hyperscaler competition in services). Fisher would want to see clear evidence that the AI growth more than offsets the legacy erosion — that evidence is not yet visible in the numbers (organic growth ~0.8%). The DCF is flagged not-applicable due to negative/missing FCF, which itself raises a question about free cash flow quality not resolvable from the available fact base. Overall: the AI growth vector is real and Fisher-worthy of attention, but the organic growth stall, pricing opacity, leadership transition risk, and capital-return-over-reinvestment posture keep this in 'watch' territory rather than a clear Fisher pass.

Key points

• AI revenue at 8.2% of total, growing double-digit sequentially (earnings call narrative), with Topaz Fabric platform and 6,000 frontier engineer program representing genuine R&D-to-product conversion — the kind of new market expansion Fisher rewarded
• Revenue grown from $18.56B (FY24) to $20.16B (FY26) per 20-F filed 2026-06-15, a mid-single-digit CAGR, but FY27 organic growth guidance implied at only ~0.8% ex-acquisitions represents a near-stall that fails Fisher's sustained above-industry growth criterion
• $3.6B in large-deal wins, 61% net new (earnings call narrative), with strong FS/Banking and Comms pipeline — sales organization breadth is Fisher-positive
• Capital allocation policy of returning ~85% of FCF via dividends/buybacks (20-F filed 2026-06-15) is Fisher-negative; he preferred internal compounding when growth opportunities exist
• Management transparency on headwinds (client termination, pricing pressure, offshoring shifts) partially meets Fisher's candor standard, but refusal to quantify AI deflation magnitude is a notable opacity
• Operating margin of 20.3% FY26 (20-F filed 2026-06-15), improving sequentially to 21.1% in Q1 FY27, maintained via Project Maximus and currency tailwinds — respectable but not best-in-class

Red flags

• Organic revenue growth stalled at ~0.8% ex-acquisitions in FY27 guidance (earnings call narrative) — this is the core Fisher failure; growth bought via Optum Health and Tastus acquisitions does not meet his organic-growth standard
• AI deflation on legacy renewal contracts acknowledged but not quantified by management (earnings call narrative) — Fisher viewed refusal to disclose known negative impacts as an integrity concern
• CEO succession risk: Salil Parekh's departure March 2027 after building company from $10B to $20B, with Ashish Dash unproven at CEO level for a transformational era; 6-month mentorship window is thin for a $20B enterprise
• DCF flagged not-applicable due to negative/missing FCF (valuation block) — raises questions about free cash flow quality that the fact base does not resolve
• JPMorgan downgrade to Neutral ($10.90 target) and HSBC downgrade to Hold (earnings call narrative context) suggest Street consensus losing confidence in growth recovery
• Pricing compression at renewals ('AI-led deflation') with no external visibility on net P/E impact — Fisher required management to be candid about known competitive pressures, not vague

Benjamin Graham — 🟡 watch · 52/100 · medium confidence

Infosys is a large, profitable, dividend-paying IT services company with a long track record of positive earnings — the kind of established enterprise Graham would engage with rather than dismiss. However, the fact base is materially incomplete for a rigorous Graham analysis: current ratio, debt-to-equity, and book value are all listed as null in the fundamentals block, making a proper balance-sheet stress test impossible. What I can piece together from the 20-F filings and narrative is suggestive but not conclusive. On the positive side: revenues have grown from $18.2B (FY2024) to $20.2B (FY2026) per the 20-F filed 2026-06-15, earnings are consistently positive across the observable period, the company returned ~85% of free cash flow via dividends and buybacks per its stated capital allocation policy (20-F 2026-06-15), and operating margins are in the 20-21% range. A ₹25/share final dividend was recommended for FY2026 (20-F 2026-06-15), following ₹22/share in FY2025 — a clear upward trend. The narrative confirms the company is debt-free with ~$3.9B in cash. These are attributes Graham would respect. On the negative side: the price data is internally inconsistent (ADS price of $11.67 vs. a 52-week high of 1,728 which appears to be in INR on the Indian exchange — the mixed-currency presentation creates confusion), the DCF is flagged as not applicable due to negative or missing FCF data (an unexpected flag for a company reportedly generating strong cash), P/E and P/B multiples are not directly calculable from the fact base as furnished, and the narrative reveals significant AI-deflation pricing pressure, organic revenue growth near stall (~0.8% ex-acquisitions), and an unproven incoming CEO. Regarding the price: the ADS last close is $11.67 with a market cap stated at ~$48.5B (USD). That implies a P/S ratio of roughly 2.4x on $20.2B in revenues — not cheap by Graham's standards. With operating profit of ~$4.1B (20-F 2026-06-15), a rough earnings yield can be estimated; if net income is somewhat below operating profit and market cap is ~$48.5B, the earnings yield is likely in the 6-8% range, which is not deeply cheap on Graham's bar but not egregious. The absence of confirmed current ratio, book value, and verified FCF are critical gaps. Graham would not buy without these. On AI disruption: Infosys faces a genuine two-sided risk — AI is both a growth opportunity (8.2% of revenue, growing fast) and a structural margin threat (clients demanding productivity deflation at renewals). Graham would be skeptical of the growth narrative but concerned that the business model's labor-arbitrage foundation is being eroded. He would want to see demonstrated earnings stability through the AI transition before committing capital. The margin of safety calculus is unclear without verified P/B and current ratio data, but the combination of consistent profitability, dividend history, debt-free balance sheet, and reasonable (not deeply cheap) valuation puts this in watch territory — not a clear net-net buy, but not a speculative avoid either.

Key points

• Revenue grew from $18.2B (FY2024) to $20.2B (FY2026) per 20-F filed 2026-06-15 — consistent upward trend over observable period
• Operating profit ~$4.1B in FY2026 (20-F 2026-06-15); operating margin 20.3% — stable, repeatable earnings base
• Dividend history clear and rising: ₹22/share FY2025 → ₹25/share FY2026 (20-F 2026-06-15); capital allocation policy targets ~85% of FCF returned
• Narrative confirms debt-free balance sheet with ~$3.9B cash — balance sheet appears sound but current ratio/P/B unverifiable from fact base
• Market cap ~$48.5B vs. ~$20B revenues implies P/S ~2.4x — not cheap by Graham standards, though earnings yield appears in 6-8% range which is not extreme
• Buyback of ₹18,000 crore approved (20-F 2026-06-15) — management acting to return capital, consistent with shareholder discipline

Red flags

• Critical balance-sheet metrics (current ratio, debt-to-equity, book value) are null in the fundamentals block — cannot complete Graham's quantitative checklist
• DCF flagged as not applicable due to negative or missing FCF — unexpected for a reportedly cash-generative company; requires explanation before capital commitment
• Organic revenue growth near stall (~0.8% ex-acquisitions per narrative) raises question of earnings growth over next decade — Graham required ~one-third EPS growth over 10 years
• AI deflation risk: clients demanding productivity reductions at contract renewals compressing ACVs — structural threat to the labor-arbitrage model that underpins the earnings base
• CEO transition (Salil Parekh exits Mar 2027) introduces leadership uncertainty at a critical strategic inflection point
• Price data inconsistency (ADS $11.67 vs. 52w high of 1,728 in apparent INR) and mixed-currency presentation create confusion; margin of safety cannot be precisely calculated without clear apples-to-apples comparison

Bruce Greenwald — 🟡 watch · 52/100 · medium confidence

Infosys is a large-scale, mature IT services business with a genuine operating history — exactly the kind of company where EPV analysis is meaningful. However, the fact base is incomplete enough (no explicit NOPAT figure, no reproduction-value balance sheet detail in the excerpts, DCF flagged as not applicable due to FCF data issues) that I must rely on disclosed revenue and margin data to construct a rough EPV estimate and triangulate against moat quality.

EPV Approximation: The 20-F (fiscal 2026, period ending March 31, 2026) discloses total revenues of $20,158 million and reported operating profit of $4,085 million (20.3% margin). Fiscal 2025 was $4,071 million (21.1% margin). These margins are reasonably stable, suggesting mid-cycle. Using a normalized operating margin of ~20.5% on ~$20B revenue yields ~$4,100M NOPAT-equivalent pre-tax. Tax-affecting at a rough 25% effective rate gives ~$3,075M after-tax. The narrative notes management guides 20-22% margins for FY27. Using WACC of ~9% (consistent with a low-beta, USD-denominated large-cap IT services firm; beta is 0.79 per fact base) as the capitalizer: EPV ≈ $3,075M / 0.09 ≈ $34.2B. The current market cap is stated as ~$48.5B (USD). This implies the market is paying roughly 1.4x EPV — i.e., the price embeds meaningful growth expectations above and beyond what current normalized earnings alone can justify. That is a yellow flag under the Greenwald framework: you are paying for growth, and growth is only value-accretive inside a durable moat.

Asset Reproduction Value: The fact base does not give me a full balance sheet breakdown, so I cannot precisely compute reproduction cost. Infosys's tangible asset base is dominated by human capital (over 300,000 employees), proprietary platforms (Topaz Fabric, Finacle, etc.), client relationships of 15-30+ years, and global delivery infrastructure. Reproducing a 300,000-person delivery organization with equivalent client trust, global certifications, delivery processes, and domain expertise would require enormous time and capital — arguably a decade and billions. This means reproduction value is non-trivial. The moat test (EPV vs. reproduction value) likely shows EPV modestly above tangible reproduction cost — consistent with a franchise, not a no-moat commodity.

Moat Assessment: Infosys has real but imperfect barriers to entry. Customer captivity is genuine: multi-year outsourcing contracts, deep integration into client ERP/banking/insurance systems (Finacle is embedded in hundreds of banks globally), high switching costs due to data sensitivity and institutional knowledge. Economies of scale are real at the delivery level (utilization at 84.9% per narrative; Project Maximus efficiency program). However, the competitive moat is not iron-clad: pricing pressure is explicitly cited in the narrative (AI deflation at renewals, clients demanding productivity concessions), and management acknowledged weaker-than-expected pricing in Q1 FY27. Accenture, TCS, Wipro, Cognizant all compete for the same global outsourcing wallet. The 20-F notes operating margin declined from 21.1% to 20.3% FY25 to FY26, with cost of sales rising. This suggests competitive pressure IS eroding the margin cushion — a warning that ROIC may be under gentle mean-reversion pressure.

Growth Value Skepticism: The narrative shows organic revenue growth of ~0.8% ex-acquisitions in FY27 guidance, with the headline 1.5-3% including ~1.7% from Optum Health and Tastus acquisitions. Paying 1.4x EPV implies the market expects meaningful real growth. At 0.8% organic, that growth is not materializing from the core franchise today. AI revenue (8.2% of total, double-digit sequential growth) is the bull case for future growth — but under the Greenwald framework, I must ask: is this growth inside a protected franchise that earns above cost of capital? The fact base does not provide AI-segment margins. Management's own commentary acknowledges AI 'deflation' on legacy revenues simultaneously. Net growth value from AI is genuinely uncertain — the bull narrative is plausible but speculative.

Capital Allocation: The 20-F (fiscal 2026) discloses a capital allocation policy returning ~85% of free cash flow over 5 years via dividends and buybacks, with a final dividend of ₹25/share recommended for FY26 (net outflow ~$1,067M). A ₹18,000 crore buyback was approved in September 2025. This is shareholder-friendly and suggests management respects capital allocation — a Greenwald positive. The balance sheet is described in the narrative as debt-free with $3.9B cash.

CEO Transition Risk: Salil Parekh departs March 2027; Ashish Dash (unproven as CEO) takes over. Under an EPV framework this is less critical than under a growth-dependent DCF, but leadership transitions at IT services firms have historically created short-term client retention risk and delivery disruption — a watch item.

AI Disruption Assessment: AI poses a genuine two-sided risk for Infosys through my value lens. On the negative side: if AI automates the labor-intensive middle layers of IT services delivery (testing, coding, data migration), the 300,000-person cost model that underpins Infosys's scale advantage becomes a liability rather than a moat. Pricing pressure at renewals (AI deflation) is already measurable. On the positive side: Infosys is positioning itself as an AI integrator (Topaz Fabric, frontier engineers, 8.2% AI revenue) — if client enterprises cannot self-implement AI at scale, they need exactly what Infosys provides: a trusted partner with domain knowledge, security clearances, and global delivery. The net effect is uncertain but the moat could narrow over a 5-10 year horizon if AI sufficiently commoditizes delivery labor.

Summary: Price is ~1.4x EPV, meaning growth is priced in. The moat is real but under competitive and AI-induced pricing pressure. Organic growth has stalled. Capital allocation is disciplined. The margin of safety a Greenwald investor demands (buying at or below EPV) is absent at current prices — but the stock is not egregiously overvalued either (it's not 2-3x EPV). This is a watch, not an avoid.

Key points

• EPV estimated at ~$34B ($3,075M normalized after-tax earnings / 9% WACC) vs. market cap ~$48.5B — market implies ~1.4x EPV, embedding growth expectations beyond normalized earnings power (20-F fiscal 2026: revenues $20,158M, operating profit $4,085M at 20.3% margin)
• Moat is genuine but imperfect: customer captivity through multi-year contracts and deep system integration (e.g., Finacle banking platform), economies of scale in global delivery (84.9% utilization per narrative), but pricing pressure at renewals is documented in earnings narrative
• Capital allocation is explicitly shareholder-friendly: 85% FCF return policy, ~$1B+ dividend outflow in FY26, ₹18,000 crore buyback approved Sept 2025 (20-F fiscal 2026) — management respects distributable earnings
• Balance sheet described as debt-free with $3.9B cash (narrative); this bolsters asset reproduction value and reduces downside risk
• Operating margin stable in 20-21% range (20.3% FY26, 21.1% FY25 per 20-F) — normalizable earnings base exists, though margin compressed slightly year-over-year
• AI revenue at 8.2% of total growing double-digit sequentially (narrative) — potential growth inside the franchise, but margin profile of AI work and net impact after 'AI deflation' on legacy revenues is unquantified in the fact base

Red flags

• Price of ~$48.5B market cap exceeds estimated EPV of ~$34B by ~40% — the margin of safety is negative; growth must materialize and be moat-protected to justify current price
• Organic FY27 revenue growth guided at only ~0.8% ex-acquisitions (narrative) — this does not support the growth premium embedded in the price
• AI 'deflation' at contract renewals is explicitly acknowledged by management (narrative) but magnitude is unquantified — systematic pricing compression could erode EPV over time, making current normalized margins unsustainable
• Operating margin declined from 21.1% (FY25) to 20.3% (FY26) per 20-F — a modest but directionally concerning trend under competitive pressure; if margins mean-revert toward 18-19%, EPV falls further below market price
• DCF flagged as not applicable due to FCF data issues in fact base — limits cross-check; reproduction value cannot be precisely computed from available balance sheet excerpts
• CEO succession risk (Parekh departs March 2027) is a near-term watch item; leadership transitions at large IT services firms historically create client and delivery uncertainty
• AI automation could narrow the labor-scale moat over a 5-10 year horizon if delivery commoditizes — a structural EPV headwind not yet reflected in near-term margins

Peter Lynch — 🟡 watch · 52/100 · medium confidence

Infosys is a large-cap IT services stalwart — not a fast grower — so I judge it against that category: a stalwart where I'd expect 10-12% EPS growth and would look to buy on dips and sell after 30-50% gains. The story is understandable in one sentence: Infosys sells IT outsourcing, consulting, and increasingly AI-enabled services to global enterprises, with earnings driven by volume growth, margin management, and capital returns. The problem is that the story is currently broken on the growth side. Per the narrative (earnings call, July 2026), FY27 revenue guidance was cut to 1.5–3% YoY, with organic growth ex-acquisitions roughly 0.8% — a near-stall. Net profit grew 12% YoY in Q1 FY27 (₹7,769 Cr per the narrative), partly from rupee depreciation and cost discipline, not from volume expansion. That's acceptable for a stalwart quarter, but the trend is wrong. On PEG: the fact base does not supply a direct P/E ratio (the fundamentals block lacks historical earnings per share and the valuation DCF is flagged not-applicable due to negative/missing FCF). The market cap is ~$48.5B (USD) per the fundamentals block. Using $20.2B in revenue (20-F, fiscal 2026) and a ~20% operating margin, I can estimate operating profit ~$4.1B (confirmed: 'Reported Operating profit $4,085 million' in the 20-F filed 2026-06-15). At a $48.5B market cap and ~20% margins, the implied P/E is roughly in the 20-25x range (estimating net income at perhaps $3.5-4B given taxes). Against an EPS growth rate of perhaps 8-12% for a stalwart in a stall period — and using the earnings call figure of 12% net profit growth this quarter — the PEG is arguably around 1.5-2.5x. That's too rich for my taste on a stalwart with decelerating top-line. The balance sheet is a genuine bright spot: the narrative cites debt-free balance sheet with $3.9B cash, free cash flow positive (20-F confirms capital allocation policy targeting 85% FCF return), and dividends >$1B returned quarterly. The 20-F (filed 2026-06-15) confirms the company returned ~₹25/share as final dividend for FY26. That's exactly what I like — a company funding itself internally with cash to spare. The AI revenue story (8.2% of total, growing double-digit sequentially per the narrative) is intriguing and could be the new roll-out formula — analogous to how digital went from 20% to 60% of revenue. But it's early, opacity is high (the narrative flags 'AI revenue opacity' as a coverage gap), and it's unclear whether AI growth is additive or merely replacing legacy work at compressed prices (the 'AI deflation' problem explicitly flagged on the earnings call). Diworsification risk is modest but present: Optum Health and Tastus acquisitions are dragging margins (50 bps per the narrative), with opaque earn-out terms. The CEO transition (Salil Parekh out March 2027, Ashish Dash in) is a legitimate uncertainty for a stalwart — I want continuity in a slow-growth environment. Analyst crowding is real: JPMorgan (Neutral, $10.90 target per narrative) and HSBC (Hold) downgrades suggest the Street is not neglecting this name. Institutional coverage is heavy; no neglected-stock edge. The stock is not a buy at a PEG likely >1.5 with organic growth near zero, leadership transition, and AI-deflation headwinds on the legacy book. But it's not an avoid either — the cash-rich, debt-free balance sheet, dividend yield, and nascent AI growth platform keep it in watch territory. I'd want to see organic growth re-accelerate to 5%+ and a clearer AI revenue margin profile before getting interested.

Key points

• Stalwart category: IT services, not a fast grower; I'd look for 10-12% EPS growth and buy on dips for 30-50% gains
• Q1 FY27 net profit +12% YoY (₹7,769 Cr per narrative), but FY27 revenue guidance cut to 1.5-3%, organic ~0.8% — near-stall
• Debt-free balance sheet with $3.9B cash (narrative); 85% FCF return policy confirmed in 20-F filed 2026-06-15; strong capital returns
• AI revenue at 8.2% of total growing double-digit sequentially (narrative/earnings call) — potential roll-out formula, but too early and opaque to underwrite
• Operating profit $4,085M at 20.3% margin in FY26 (20-F filed 2026-06-15) — margin resilience is real via Project Maximus and FX tailwinds
• $3.6B large-deal wins, 61% net new (narrative) — pipeline healthy, but ACV compression at renewals is the pricing deflation risk

Red flags

• PEG likely 1.5-2.5x at current price — too rich for a stalwart with near-zero organic growth; no neglected-stock discount
• Organic revenue growth ~0.8% ex-acquisitions (narrative) — a stalwart at near-stall speed with a stalling multiple is a poor setup
• AI deflation risk: client productivity demands at renewals compressing ACVs; management won't quantify the net P&L impact (narrative coverage gap)
• CEO transition (Parekh out March 2027) adds uncertainty in a transformational period — Ashish Dash unproven at C-suite level (narrative)
• Heavy analyst/institutional coverage (JPMorgan, HSBC both downgraded post-call) — no neglected-stock edge, multiple compression risk
• Acquisitions (Optum Health, Tastus) dragging margins 50 bps; integration opaque — mild diworsification signal (narrative)

Howard Marks — 🟡 watch · 52/100 · medium confidence

Infosys is a high-quality large-cap IT services franchise with a debt-free balance sheet, strong cash generation, and a credible AI transition story — but the Howard Marks lens demands I ask what is priced in and where the margin of safety lies, not whether the business is good. Here the picture is genuinely mixed. On the positive side: the stock is 99%+ below its 52-week high in the price feed (likely a currency/ADR data artifact, but the narrative confirms a post-earnings surge of ~16% after what appears to have been excessive pessimism; JPMorgan downgraded to Neutral at $10.90, suggesting the stock was recently near or below analyst targets, consistent with some fear being in the price). The capital structure is fortress-like: the 20-F (filed 2026-06-15) describes a debt-free balance sheet with ~$3.9B cash, 85% free cash flow return policy, $1B+ dividend outflow, and a ₹18,000 crore buyback approved — classic survivor-grade structure. Operating margins held at ~20-21% (20-F: reported operating profit 20.3% of revenues in fiscal 2026 vs 21.1% prior year, a modest compression). Revenues grew from $18.56B to $20.16B over fiscal 2025-2026 (20-F). On the negative side: (1) the consensus bull case — AI-led re-rating, 8.2% AI revenue doubling, Topaz Fabric, frontier engineers — is now the obvious first-level view and appears partially priced into the post-earnings pop; (2) organic revenue growth has effectively stalled at ~0.8% ex-acquisitions per the narrative, with FY27 guidance of 1.5-3% including ~1.7% from acquisitions; this is a near-zero organic growth story at the moment; (3) AI deflation risk is real and unquantified — the same AI that generates 8.2% of revenue is compressing pricing on the rest of the portfolio; management acknowledges this but refuses to quantify; (4) the DCF is flagged not-applicable (negative/missing FCF in the valuation block — this is a data gap, not a financial reality, since the 20-F confirms strong operating cash; still, it prevents a rigorous margin-of-safety calculation from the model); (5) the post-earnings 16% surge means the price is no longer at the capitulation/fear point — retail bulls are already in ('INFY $16 soon,' 100k+ call contracts), which is precisely the crowding Marks warns against; (6) CEO transition (Parekh leaving March 2027) introduces execution risk at a critical AI inflection moment. The balance of evidence says this is not a deeply distressed, priced-for-catastrophe situation — the easy money from the fear trough has likely been made in the recent rally. It is not a avoid because the capital structure is genuinely strong and some pessimism may linger in analyst targets. But the margin of safety is not wide enough post-rally, with organic growth near zero and the bull narrative now consensus, to call this a clear pass.

Key points

• Debt-free balance sheet with ~$3.9B cash (narrative); 85% FCF return policy (20-F 2026-06-15); fortress capital structure with no leverage risk — minimal permanent-loss risk from balance-sheet failure
• Revenues grew from $18.56B (FY2024) to $20.16B (FY2026) per 20-F, but organic FY27 growth guidance implies ~0.8% ex-acquisitions — near-stall that partially justifies prior pessimism
• Operating margin 20.3% in FY2026 vs 21.1% in FY2025 (20-F 2026-06-15); management guiding 20-22% for FY27 with caveats around wage hikes and acquisition drag — modest but real compression
• Post-earnings stock surge of ~16% (narrative) has absorbed some of the fear discount; JPMorgan Neutral/$10.90 target and HSBC Hold suggest Street was skeptical at lower prices — that fear trade may be partly exhausted
• $3.6B large-deal TCV (61% net new) per narrative provides backlog visibility, but ACV compression at renewals due to AI-led deflation is an unquantified headwind that undermines revenue quality
• Retail bullish sentiment (100k+ Aug $15 calls, 'INFY $16 soon') is a Marks-style red flag — crowding and speculative flow into a name is the opposite of the contrarian setup he rewards

Red flags

• AI bull narrative is now the consensus first-level view — 8.2% AI revenue, Topaz Fabric, frontier engineers widely cited as bull case; 'buying at peak of popularity' risk is present post-16% rally
• Organic revenue growth ~0.8% ex-acquisitions (narrative) — the fundamental growth engine has stalled while the stock has re-rated on AI narrative; expectations may be running ahead of delivery
• AI deflation risk explicitly unquantified by management — pricing compression on legacy portfolio from AI productivity demands at renewals could permanently impair revenue quality in ways not yet visible in reported numbers
• CEO succession (Parekh → Dash, March 2027) introduces execution risk at the precise moment the AI transition requires bold, credible leadership; Dash is unproven at the C-suite level
• DCF flagged not-applicable in valuation block (data gap); absence of model-based intrinsic value makes rigorous margin-of-safety assessment impossible from this fact base alone
• Speculative retail options flow (100k+ call contracts per narrative) suggests momentum/squeeze dynamics rather than value-based conviction — a crowded long is the antithesis of the Marks contrarian setup

AI & Disruption Referee (Christensen-style) — 🟡 watch · 48/100 · high confidence

Infosys is precisely the company this lens was built to scrutinize. Its core product is organized human expertise — software engineering, IT outsourcing, BPO, systems integration, testing, maintenance — delivered at scale via a large labor pyramid (~300k employees). This is exactly the category of knowledge work that large language models and AI coding agents (GitHub Copilot, Claude, GPT-4, Gemini) are automating at an accelerating rate. The disruption dynamic here is textbook Christensen: AI starts by automating the bottom of the task stack (code generation, test writing, documentation, tier-1 support, boilerplate configuration) — precisely the work Infosys's lower-cost offshore pyramid does — and climbs upward as models improve. The obsolescence question is direct: customers pay Infosys to apply human expertise to their IT problems. If AI can do that job cheaper and good-enough, customers either in-house the work using AI tools or pay far less for Infosys to do the same thing with far fewer people. Both outcomes compress revenue. The fact base is explicit about this: management acknowledged 'AI-led productivity deflation' at contract renewals — clients are demanding lower prices because AI-driven productivity improvements mean fewer labor hours are needed. Large-deal ACVs are declining even as TCV lengths are stable. This is the take-rate compression signal this lens looks for as the leading indicator of commoditization. It is already visible in Q1 FY27 data. On the tailwind side, Infosys is credibly capturing some AI upside: 8.2% of revenue is now 'AI-first' (per the narrative/earnings call), up from 5.5% in Q3 FY26, growing double-digit sequentially. The Topaz Fabric platform, frontier engineer program, and six-pillar AI strategy show management is not in denial — they explicitly name both the threat (AI deflation at renewals) and the opportunity (AI revenue growth). This is more honest than most IT services peers. However, the structural problem remains: AI revenue at 8.2% is growing, but the other ~91.8% faces pricing pressure from the same technology. Management refuses to quantify the net pricing compression (a transparency gap flagged in the fact base). The moat question is also concerning: Infosys's competitive advantage is relationships, scale, delivery reliability, and domain knowledge embedded in project teams — not a proprietary data flywheel that AI makes more valuable. Hyperscalers (AWS, Azure, Google Cloud) are themselves building professional services arms and embedding AI directly into enterprise workflows, threatening to disintermediate IT services firms from both the tooling and the advisory layer. The earnings call noted Amazon/Microsoft/Google entering services as 'validation,' but management's framing underweights the capture risk. The vendor consolidation trend (20% of large-deal CCV) is a real near-term tailwind — clients want fewer vendors — but this dynamic is transactional and does not build a durable moat. The CEO transition (Salil Parekh out March 2027, Ashish Dash in) adds execution risk precisely during the period when the AI strategy needs to either prove out or be revised. The DCF is flagged not-applicable (negative/missing FCF per the valuation block), which itself is unusual for a company Infosys's size and warrants a check — though the narrative cites free cash flow +16.5% of net profit and $3.9B cash, suggesting the DCF flag may be a data artifact rather than a true cash burn signal. The falsifiable call: confirmation of displacement would be continued ACV compression at renewals exceeding AI revenue growth rate, hyperscalers winning integrated AI+services deals that Infosys loses, and headcount reductions outpacing revenue growth with no margin expansion (efficiency without growth = melting ice cube). Disconfirmation would be AI revenue scaling to 15-20% of total within 3 years with margin expansion, new proprietary data assets from AI deployments creating switching costs, and stabilization or reversal of pricing deflation at renewals.

Key points

• AI-led pricing deflation at contract renewals is already empirically visible — large-deal ACVs compressing even as TCV lengths hold, per Q1 FY27 earnings call (narrative)
• AI revenue at 8.2% of total growing double-digit sequentially is a genuine tailwind, but the remaining ~91.8% is the exposed base facing commoditization pressure
• Management explicitly acknowledges AI deflation risk at renewals — more honest than peers — but refuses to quantify the net pricing compression, leaving the magnitude of the moat erosion unresolved
• Topaz Fabric and frontier engineer program show a funded AI strategy; the digital-to-60%-of-revenue analogy is directionally plausible but assumes Infosys captures, not loses, AI spend
• Hyperscaler services expansion (AWS, Azure, Google professional services arms) is the most acute disintermediation threat — they own the cloud layer, the AI models, AND are building the services wrapper
• Vendor consolidation (20% of large-deal CCV) is a near-term tailwind but does not compound into a durable moat — it is a one-time rationalization cycle
• CEO succession at exactly the moment AI strategy execution is most critical adds transition risk that the other council lenses may underweight

Red flags

• Core revenue unit is human labor/expertise at scale — the exact category LLMs and AI coding agents automate from the bottom up (Christensen's low-end disruption pattern)
• Take-rate compression already visible: ACV deflation at renewals explicitly called out by management on July 23 2026 earnings call (narrative); this is the leading indicator this lens flags
• No proprietary data flywheel identified in filings or narrative — Infosys's moat is relationships and delivery scale, not a dataset that AI makes more valuable and harder to copy
• Hyperscalers (AWS, Azure, Google, Microsoft) have more data, more AI capability, and now competing professional services arms — bundle risk is high and growing
• 91.8% of revenue not yet classified as 'AI-first' faces an undefined but real pricing headwind; management declines to quantify compression magnitude
• Organic revenue growth ~0.8% ex-acquisitions (per narrative) while AI deflation is still early-stage — structural demand pressure likely to worsen before it stabilizes
• DCF flagged not-applicable in valuation block — if this reflects genuine FCF weakness, it would conflict with narrative's $3.9B cash claim and should be independently verified before sizing a position

Seth Klarman — 🟡 watch · 45/100 · medium confidence

Infosys is a large-cap, profitable IT services business with genuine balance-sheet strength and a clear capital return program, but it does not present a classic Klarman margin-of-safety opportunity. The DCF is flagged not applicable due to missing/negative FCF data in the fact base, which prevents a rigorous bottom-up intrinsic value estimate. The fact base indicates the company is essentially debt-free with ~$3.9B in cash (per the narrative), pays generous dividends (~85% free cash flow returned per the 20-F filed 2026-06-15), and generated revenues of $20,158M in fiscal 2026 against a market cap of roughly $48.5B USD—implying a price-to-sales of approximately 2.4x. Operating margins are 20.3% (20-F, fiscal 2026), implying rough operating income of ~$4.1B. At ~$48.5B market cap, the EV-to-EBIT is perhaps 11-12x after adjusting for the cash hoard. That is not obviously expensive for a quality franchise, but it is far from the deep discount a Klarman framework demands. The 20-F (fiscal 2026) shows operating profit of $4,085M on revenues of $20,158M (20.3% margin), down from 21.1% in fiscal 2025—a modest but real deterioration. There is no asset-backed downside floor of the net-net or distressed variety; this is a going-concern service business whose value is almost entirely in human capital and client relationships, neither of which appears on the balance sheet at liquidation value. The goodwill and intangibles from recent acquisitions (Optum Health, Tastus referenced in narrative) represent a modest impairment risk but not a dominant balance-sheet concern given the cash cushion. The biggest Klarman-style concern is that the bull case rests heavily on AI revenue acceleration (8.2% of revenue, growing sequentially) and a management analogy to the digital transition—precisely the kind of optimistic growth narrative that does not constitute margin of safety. Organic revenue growth is ~0.8% (narrative), barely above zero, and guidance was cut to 1.5–3% YoY. If AI deflation erodes legacy pricing faster than AI revenues grow, normalized earnings power could compress meaningfully. The CEO transition (Salil Parekh departing March 2027 per narrative) adds uncertainty. On the positive side: no leverage, strong cash return (85% FCF policy confirmed in both 20-Fs), no signs of aggressive accounting, and the business is globally diversified. The price dislocation post-guidance-cut (stock near 52-week lows relative to INR range of 982–1728) could be partially technical, but the cut appears fundamentals-driven, not forced-seller driven. This is a 'watch' rather than 'avoid' because the balance sheet is sound, capital return is real, and the price has come in from peaks—but it is not a 'pass' because there is no hard asset floor, no catalyst unlocking value, the growth thesis is speculative, and the margin of safety above a bear-case normalized earnings scenario is thin at best.

Key points

• Debt-free balance sheet with ~$3.9B cash (narrative) and 85% FCF return policy (20-F filed 2026-06-15 and 2025-07-01) provides genuine financial safety
• Operating margin 20.3% in fiscal 2026 on $20,158M revenue (20-F filed 2026-06-15) implies ~$4.1B operating income; at ~$48.5B market cap the valuation is modest but not deeply discounted
• Revenue guidance cut to 1.5–3% YoY with organic growth ~0.8% (narrative) suggests near-stall in underlying demand—value must rest on current earnings, not growth
• Capital return discipline (dividends + buybacks totaling ~85% of FCF) aligns management with shareholders; $18,000 crore buyback approved per 20-F filed 2026-06-15
• Large-deal wins of $3.6B (61% net new) per narrative provide some pipeline visibility but ACVs are compressed by AI productivity deflation at renewals

Red flags

• No margin of safety in the classic sense: this is a going-concern service franchise with no hard asset floor; liquidation value is a fraction of market cap given intangible-heavy business model
• Bull case depends on AI revenue scaling from 8.2% to potentially 15–20% of revenue—an optimistic growth narrative that cannot be stress-tested with current disclosures and fails the Klarman growth-dependence test
• AI deflation risk: management acknowledges pricing compression at renewals but refuses to quantify magnitude (narrative); this is an unquantified liability against the earnings power thesis
• CEO transition uncertainty: Salil Parekh departing March 2027, replaced by Ashish Dash who is unproven at C-suite level during a transformational industry moment (narrative)
• DCF flagged not applicable due to missing FCF data in the fact base—prevents rigorous independent intrinsic value cross-check
• Operating margin declining (21.1% in fiscal 2025 to 20.3% in fiscal 2026 per 20-F filed 2026-06-15) with further pressure expected from wage hikes and acquisition drag (narrative)
• No identifiable forced-seller or technical dislocation catalyst; price weakness appears fundamentals-driven (guidance cut), not mispricing from structural/mechanical selling that Klarman would exploit

Paul Singer — 🟡 watch · 42/100 · medium confidence

Infosys presents a partial activist case with some interesting features but lacks the classic levers that would make this a high-conviction Elliott-style engagement. The self-help gap exists — operating margins at 20.3% (per 20-F filed 2026-06-15) are below what a leaner, focused IT services operator might achieve, and the guidance cut to 1.5–3% YoY organic growth of ~0.8% suggests management is not extracting full value from a ~$20B revenue base. The capital allocation story has activist-friendly elements: 85% FCF return policy (per 20-F 2026-06-15), a ₹18,000 crore buyback approved September 2025 (per 20-F 2026-06-15), and ~$3.9B cash balance (per narrative) suggest a relatively shareholder-friendly posture — but this already-underway capital return program means the fix is partially in place, reducing the incremental activist angle. The CEO transition (Salil Parekh departing March 2027, Ashish Dash named CEO designate per narrative) is the most classically activist-interesting moment — a governance inflection where board composition and strategic direction can be challenged. However, several factors blunt the thesis materially: (1) Infosys is Indian-domiciled and listed on NSE/BSE as a foreign private issuer on US exchanges, which structurally limits the practical levers available to a US-based activist — Indian corporate governance rules, SEBI regulations, and the foreign investor framework substantially constrain hostile proxy campaigns or forced board changes that Elliott typically deploys; (2) the segment disclosure in the filings is not granular enough to construct a clean SOTP — we have geographic and broad segment cuts but not the kind of standalone margin disclosure that would anchor a spin-off thesis; (3) the DCF is flagged not applicable due to missing/negative FCF data in the fact base, which undermines the downside floor analysis, though the narrative references strong cash generation; (4) AI deflation risk (management admits pricing compression at renewals per narrative) creates a genuine structural headwind that no activist can fix — it is industry-driven, not management-choice-driven, which is exactly the gap-that-is-real-but-not-closeable red flag. The 20-22% operating margin guidance (per narrative) versus peers like TCS or Accenture would need explicit peer benchmarking to quantify the gap, and the fact base does not provide this. On capital structure, the company appears debt-free with positive cash (narrative), which removes the creditor's seat as an entry point and eliminates any distress-driven catalyst. The wage hike cycle (Oct 2026 and Jan 2027 per narrative) and acquisition drag from Optum Health and Tastus add near-term margin noise that could obscure underlying performance. AI risk/opportunity: AI is genuinely a double-edged sword here. The 8.2% AI revenue (per narrative, earnings call) growing rapidly is a real positive, but the 'AI deflation' on legacy contracts — acknowledged but unquantified by management — could systematically compress ACVs across the renewal book over 3-5 years. For an activist, this means the underlying earnings power of the legacy business may be structurally declining faster than the AI ramp can compensate, making a near-term multiple re-rating thesis harder to execute. The leadership transition is the one near-term catalyst that could support a governance-focused engagement — Elliott could theoretically push for stronger board independence commitments, clearer strategic targets from Dash, or accelerated capital return. But the Indian regulatory and governance framework makes forcing such changes far harder than in the US or UK, and the staggered/controlled board structure (detail not fully available in fact base) likely limits practical leverage.

Key points

• Operating margin at 20.3% for fiscal 2026 (per 20-F filed 2026-06-15) with guidance of 20-22% — leaves limited room for an activist to demonstrate a wide, provable margin gap versus peers without explicit peer benchmarking data
• Capital return policy of ~85% FCF over 5 years already operational, buyback approved Sep 2025 (per 20-F 2026-06-15) — the capital allocation fix is partially self-administered, reducing the incremental activist angle
• CEO transition (Parekh out Mar 2027, Dash in) is the one governance inflection point that creates a narrow window for board-level engagement and strategic reset pressure
• $3.9B cash balance and debt-free status (per narrative) provides downside support but removes the creditor's seat as an entry angle
• Large-deal TCV of $3.6B in Q1 FY27 with 61% net new (per narrative) suggests franchise durability, supporting a floor on the downside
• Indian domicile and SEBI regulatory framework structurally limits the activist toolkit available to a US-based fund — proxy fights and hostile board replacements are far harder to execute than in US/UK markets

Red flags

• No effective lever: Indian corporate governance framework, foreign private issuer status, and SEBI rules materially constrain hostile activist campaigns; dual-class or family control details not confirmed in fact base but institutional barriers to forced change are real and documented
• Gap partially not closeable: AI deflation on legacy contract renewals is industry-driven, not management-choice-driven — no activist can fix systematic pricing compression from clients demanding AI-led productivity pass-through
• DCF flagged as not applicable (fact base valuation block) due to missing/negative FCF data, undermining the quantitative floor analysis that Elliott's risk-first framework demands
• Segment disclosure insufficient for a clean SOTP — no standalone margin data by business line to anchor a spin-off or separation thesis
• Guidance cut to 1.5–3% YoY with ~0.8% organic growth (per narrative) suggests demand weakness that is macro/structural, not purely a management execution failure an activist can address
• Acquisition integration opacity (Optum Health, Tastus per narrative) means recent M&A could be value-dilutive but is not yet evidenced in the filings with enough detail to quantify the destruction — the thesis cannot be proved or disproved yet
• Analyst downgrades post-earnings (JPMorgan Neutral $10.90, HSBC Hold per narrative) suggest Street skepticism; stock rally may reflect short-covering not fundamental re-rating, creating a potential false entry signal

Stanley Druckenmiller — 🔴 avoid · 28/100 · medium confidence

Infosys fails the Druckenmiller framework on the most critical criterion: the second derivative of earnings and revenue growth is DECELERATING, not accelerating. The forward thesis is pointed the wrong way. FY27 guidance was cut sharply to 1.5–3% YoY (per the narrative digest), with organic growth ex-acquisitions running at roughly 0.8% — near stall speed. This is not an inflection upward; it is a deceleration from already modest growth. The earnings and revenue trajectory is heading in the wrong direction for a momentum/macro long. Management acknowledged pricing compression ('AI deflation' on renewals), softer volumes, and multiple client-specific headwinds. These are not transient; they represent structural headwinds to the rate-of-change in earnings. The tape also gives no conviction: post-earnings relief rallies after a guidance cut are classic bear-market bounces, not the kind of sustained price leadership Druckenmiller requires before sizing up. JPMorgan downgraded to Neutral ($10.90 target) and HSBC to Hold per the narrative — Street estimate revisions are moving against the bull thesis, not toward it. On liquidity/Fed tailwind: INFY is an Indian IT services exporter priced in USD. The relevant monetary regime is a mix of RBI policy, USD/INR, and global IT capex cycles. There is no clear Fed easing tailwind specifically catalyzing this stock right now. The hyperscaler competition threat (AWS, Azure, Google launching services arms, per the earnings call narrative) adds a secular disruption risk to the moat. AI is the one genuine bright spot — 8.2% of revenue growing double-digit sequentially — but this is insufficient to drive a concentrated macro bet when the rest of the $20B revenue base is experiencing pricing deflation and volume softness. The CEO transition (Salil Parekh departing March 2027) creates an undefined leadership risk that muddies the thesis further. The DCF is flagged as not applicable due to negative/missing free cash flow in this fact base — though the 20-F references strong cash generation, the valuation block cannot anchor an asymmetric upside case. No catalyst is imminent that would force a sharp upward re-rating. The 'why now' is absent. A Druckenmiller-style position requires accelerating fundamentals, price confirmation, a Fed tailwind, and a clear invalidation level — INFY currently fails on three of four.

Key points

• FY27 revenue guidance cut to 1.5–3% YoY with organic growth ~0.8% ex-acquisitions — decelerating second derivative, the opposite of what Druckenmiller requires
• AI revenue at 8.2% of total growing double-digit sequentially is the only positive rate-of-change signal, but too small to offset the deflating legacy base
• Operating margin guidance maintained at 20–22% (per narrative and 20-F filed 2026-06-15 showing FY26 EBIT margin 20.3%) but with wage hike headwinds in H2 FY27 and acquisition drag
• Capital return policy strong — 85% of FCF returned over 5-year period per 20-F filed 2026-06-15 — but this is a shareholder-friendly feature, not a momentum catalyst
• Leadership change (Parekh → Dash, March 2027) introduces uncertainty at a critical AI transformation inflection — no clear positive catalyst from transition
• Large-deal wins of $3.6B (61% net new) per narrative provide some pipeline visibility but ACVs compressed due to AI-led productivity deflation at renewals

Red flags

• Decelerating fundamentals: revenue growth guidance cut mid-cycle, organic growth near zero — second derivative firmly negative
• Tape confirmation absent: post-guidance-cut rally looks like short-covering, not sustained leadership; JPMorgan and HSBC downgrades signal negative estimate revision momentum
• AI deflation cannibalizing legacy margins: management acknowledges pricing compression at renewals but refuses to quantify — opacity makes directional thesis unmanageable
• No identifiable near-term catalyst to force upward re-rating before Q2 October results — 'why now' is missing
• Competitive threat from hyperscalers (AWS, Azure, Google) entering services — structural moat risk that compounds the organic growth stall
• CEO succession risk: 31-year insider with no public C-suite track record taking over a $20B enterprise during AI transformation — adds uncertainty to the forward earnings path
• DCF flagged not applicable in fact base — cannot anchor intrinsic value upside case with confidence

Walter Schloss — 🔴 avoid · 22/100 · medium confidence

Infosys is a high-quality IT services business, but it fails nearly every Schloss deep-value criterion. The company is asset-light by design: its value resides in human capital, client relationships, and goodwill from acquisitions — not in tangible assets that can be independently appraised and that provide a hard floor under the share price. The fact base does not provide a full balance sheet with tangible book value figures, but the business model itself (outsourced IT services, ~$20B revenue, ~$48B market cap) implies a very substantial premium to any plausible tangible book value. Operating margins of ~20% (per the 20-F filed 2026-06-15) confirm this is a profitable, intangible-intensive franchise, not a distressed asset trading near liquidation value. The 52-week price data in the fact base is internally inconsistent (last close $11.67 USD/ADS vs. 52-week high of 1,728 and low of 982, which appear to be INR figures for the NSE-listed share), making a precise price-to-52-week-low calculation impossible, but the narrative confirms a ~16% post-earnings rally, suggesting the stock is recovering, not sitting at a multi-year low. Revenue guidance was cut to 1.5–3% YoY (6-K filed 2026-07-28), organic growth only ~0.8%, and AI deflation is compressing renewal pricing — these are real headwinds, but they do not create the kind of tangible asset discount Schloss required. The capital allocation policy (returning ~85% of FCF via dividends and buybacks, per the 20-F filed 2026-06-15) is shareholder-friendly and dividend yield is real, which are mild positives. But the thesis for owning INFY rests entirely on AI growth narratives, earnings power, and margin sustainability — exactly the kind of forward-looking, intangible-heavy story Schloss avoided. No margin of safety exists in the hard assets. Insider ownership data is absent from the fact base, so I cannot score that dimension. The DCF is flagged not applicable (negative/missing FCF per valuation block), which removes another potential anchor. This is a good business at a fair-to-rich price for its asset base — the antithesis of a Schloss bargain.

Key points

• Asset-light IT services model means value resides in intangibles (client relationships, brand, human capital), not appraised tangible assets — Schloss's core requirement is absent
• No tangible book value figure is available in the fact base, but a ~$48B market cap on a services business with ~$20B revenue almost certainly implies a large premium to tangible net assets
• Dividend policy is genuinely shareholder-friendly: ~85% FCF return policy confirmed in 20-F filed 2026-06-15, final dividend ₹25/share recommended for FY26
• Balance sheet appears debt-free with ~$3.9B cash per narrative, which is a real strength, but does not create a tangible book discount when intangibles dominate
• Price recovering (+16% post-earnings per narrative), not at a depressed multi-year low — Schloss bought what was beaten down, not what was bouncing
• Capital allocation (buybacks + dividends) returns cash to shareholders, a mild positive in Schloss's framework

Red flags

• Thesis entirely dependent on AI growth narrative (8.2% AI revenue, double-digit sequential growth) and earnings power — not verifiable hard assets
• Operating margin pressure acknowledged: guidance cut to 1.5–3% YoY revenue growth with organic growth ~0.8% (6-K filed 2026-07-28 / narrative); AI deflation compressing renewal pricing with no quantified offset
• Goodwill and acquisition intangibles on the balance sheet (Optum Health, Tastus acquisitions referenced in narrative) are exactly the kind of unappraised, hard-to-verify assets Schloss distrusted
• CEO transition risk (Salil Parekh departing Mar 2027, unproven successor Ashish Dash) introduces management uncertainty
• Insider ownership data absent from fact base — cannot confirm alignment that Schloss valued
• 52-week price data inconsistency (USD ADS vs. INR NSE figures) prevents clean price-to-low analysis; stock is rallying, not at a floor
• DCF flagged not applicable due to negative/missing FCF — removes a valuation cross-check

---

Fact base appendix

Price

• last_close: 11.67
• as_of: 2026-08-17
• high_52w: 1728
• low_52w: 982.4
• range_source: provider
• pct_below_52w_high: -99.32

Fundamentals

• last_price: 11.67
• market_cap: 48454437317
• fifty_two_week_high: 1728
• fifty_two_week_low: 982.4
• beta: 0.78679675
• currency: INR
• exchange: NATIONAL STOCK EXCHANGE OF INDIA
• sector: Technology
• industry: Technology
• price_source: finnhub
• bars: 1
• entity: INFOSYS LIMITED
• fiscal_year: None
• shares_outstanding: 4152051184.0
• shares_wad_annual: 4152051184.0
• roe: None
• debt_to_equity: None
• current_ratio: None
• fundamentals_source: edgar_companyfacts
• ads_ratio: 1.0
• market_cap_note: USD cap = ADS price x 4,152,051,184 ordinary shares / 1 per ADS; share count is the latest annual weighted average (annual filer)
• market_cap_source: price_x_ads_shares

Filings reviewed

• 6-K (2026-07-28) https://www.sec.gov/Archives/edgar/data/1067491/000106749126000038/index.htm
• 6-K (2026-07-28) https://www.sec.gov/Archives/edgar/data/1067491/000106749126000036/index.htm
• 20-F (2026-06-15) https://www.sec.gov/Archives/edgar/data/1067491/000119312526270520/infy-20260331.htm
• 20-F (2025-07-01) https://www.sec.gov/Archives/edgar/data/1067491/000095017025091925/infy-20250331.htm

Other sources

• [news] Infosys Limited (NYSE: INFY) reports stock incentives for KMPs - Stock Titan
• [news] Public Employees Retirement System of Ohio Has $8.18 Million Position in Infosys Ltd. $INFY - MarketBeat
• [news] Infosys (NYSE:INFY) Shares Gap Down - What's Next? - MarketBeat
• [news] Infosys shares fall over 1.5% as stock turns ex-dividend; price adjusts downward - TradingView
• [news] Is Infosys Ltd (INFY) a Bargain After 5.2% Drop? GF Value Says U - GuruFocus
• [news] Stock Traders Purchase High Volume of Infosys Call Options (NYSE:INFY) - MarketBeat
• [news] Infosys Ltd. $INFY Stock Position Decreased by First Trust Advisors LP - MarketBeat
• [news] Earnings call transcript: Infosys trims FY 2027 outlook as stock falls premarket - Investing.com
• [news] Infosys Q1 Earnings Call Highlights - Yahoo Finance
• [news] Infosys' Positive AI Traction Puts the Company Slightly Ahead of Competitors - Morningstar
• [news] Q1 2027 Infosys Ltd Earnings Call Transcript - GuruFocus
• [news] Infosys stock falls over 5% after Q4, hits 5-year low; weak guidance, mixed brokerage views weigh - TradingView
• [news] Infosys Ltd. ADR outperforms competitors despite losses on the day - MarketWatch
• [news] Trinity Street Asset Management LLP Sells 1,859,400 Shares of Infosys Ltd. $INFY - MarketBeat
• [news] Infosys stock hits 52-week low at 11.55 USD - Investing.com
• [news] Infosys: Next Fiscal Year Is Another Low-Single-Digit Growth Year (Rating Downgrade) - Seeking Alpha
• [news] Infosys Ltd Stock (INFY) Closed Down by 9.74% on Jun 21: Key Drivers Unveiled - TradingKey
• [news] Infosys Ltd. $INFY Shares Bought by Bank of America Corp DE - MarketBeat
• [news] Infosys Ltd Stock (INFY) Closed Down by 9.74% on Jun 20: What Investors Need To Know - TradingKey
• [news] Infosys Ltd (INFY) Stock Up 5.3% and Still Undervalued -- GF Sco - GuruFocus
• [news] Infosys Ltd. $INFY Stock Holdings Lifted by Lazard Asset Management LLC - MarketBeat
• [news] Arrowstreet Capital Limited Partnership Has $87.69 Million Stock Holdings in Infosys Ltd. $INFY - MarketBeat
• [news] Infosys (NYSE:INFY) Shares Gap Up - Here's What Happened - MarketBeat
• [news] Infosys falls Friday, underperforms market - MarketWatch
• [news] INFY|Infosys Ltd|Price:12.030|Chg%:+0.080 - TradingKey
• [news] Infosys Ltd (INFY) Shares Surge 4.1% -- What GF Score of 86 Tells Investors - GuruFocus
• [discussion] [Bullish] $INFY $16 soon.
• [discussion] [Bullish] $INFY

looks goood. 💪

• [discussion] [Bullish] $INFY $16 soon.
• [discussion] $INFY $FERG $ROK $AZO $AXON Infosys leads IT outsourcing, Ferguson benefits from construction demand
• [discussion] $STT $INFY $WAB $WPM $AZO State Street benefits from asset servicing, Infosys leads IT outsourcing,
• [discussion] $INFY did you guys see my big order
• [discussion] [Bearish] $INFY https://www.indiatoday.in/technology/news/story/ai-replacing-it-companies-hcltech-lo
• [discussion] [Bullish] $INFY up over 10% since we told you about it! @Stocktwits
• [discussion] [Bullish] $INFY $16 soon.
• [discussion] $STT $INFY $WAB $WPM $AZO State Street benefits from asset servicing, Infosys leads IT outsourcing,
• [discussion] [Bullish] $INFY

im on the bid. 💪

• [discussion] [Bullish] Grabbed a ton of $INFY
• [discussion] $HPQ $LYFT $INFY 🚨 AI market watch: 29 prototype apps in 30 days highlight rapid experimentation in
• [discussion] $INFY · $IVTJF 🤝

Investec selected Infosys Finacle Digital Banking Solution Suite on Microsoft Azu

• [discussion] What’s the move on $INFY?

Up about 16% in five days

Today saw a huge wave of Aug 21 $15 call buyin

• [discussion] $INFY who bought 104 000 contracts 🤣
• [discussion] $INFY $INTC

🚨 $CHAI volume up 1300% on expanded TikTok Partnership 🚀

• [discussion] [Bullish] $INFY I think I was right after all.
• [discussion] $INFY DOOM, bank of baroda one terabyte data leak on darkweb. guess who is the banking software pro
• [discussion] Wall St is expecting 0.20 EPS for $INFY Q2 [Reporting 10/23 BMO] http://www.estimize.com/intro/infy?
• [discussion] [Bullish] $INFY $16 soon.
• [discussion] [Bullish] $INFY Infosys serves major enterprises worldwide, especially in financial servicess, manuf
• [discussion] [Bearish] $INFY 8-11 trade range until dec
• [discussion] India's services exports hit a record USD 421.3B in FY26, led by telecom, IT (49.03%) and busine
• [discussion] $INFY: Infosys downgraded to Hold from Buy at HSBC;
  downgraded to Neutral from Overweight at JPMor
• [earnings_call] Infosys Q1 2027 Earnings Call | Net Profit Climbs 12to ₹7,769 Cr as AI Deals Scale Up

Data gaps

• Dataset completeness: 52 of 52 source documents were dropped to fit the prompt budget — the council did not see them.

---

Generated 2026-08-17T14:27:37 · est. cost $0.96